<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Mixed Bag-3) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 11753,
    "choices": [
      {
        "id": 46978,
        "text": "<p><span style=\"font-size:12.0pt;\">DC Cardioversion</span></p>"
      },
      {
        "id": 46979,
        "text": "<p><span style=\"font-size:12.0pt;\">Valsalva Maneuver</span></p>"
      },
      {
        "id": 46980,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
      },
      {
        "id": 46981,
        "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient comes with palpitation to ER. His Pulse-180/min and BP-70mm of Hg systolic. ECG shows narrow QRS complex tachycardia with regular heart rate. What is the next step in management? (INICET NOV 2020)</span></p>",
    "unique_key": "Q9204954",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822823,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;DC cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient presenting with hemodynamically unstable symptoms such as a significantly low blood pressure and a high heart rate, as indicated by a pulse of 180/min and systolic BP of 70 mmHg, immediate DC cardioversion is indicated. This procedure is critical for restoring normal heart rhythm and preventing further cardiovascular compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Valsalva Maneuver: </strong>it&nbsp;is typically used in stable patients to attempt cardioversion of supraventricular tachycardia (SVT) back to a normal rhythm. It is not suitable for patients showing signs of hemodynamic instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adenosine: </strong>it&nbsp;is effective in terminating certain types of SVT by temporarily blocking the AV node but is used in stable patients. Given the patient's low BP, this is not the first-line approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Verapamil:&nbsp;</strong>it&nbsp;is a calcium channel blocker used for rate control in cases of SVT, more appropriate for stable patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DC cardioversion is the emergency treatment of choice for a patient with hemodynamically unstable narrow QRS complex tachycardia, as it quickly restores normal rhythm and stabilizes the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Cardiology/SVT/chap 246</strong></span></p>",
    "correct_choice_id": 46978,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13771,
    "choices": [
      {
        "id": 55045,
        "text": "<p><span style=\"font-size:12.0pt;\">External carotid artery</span></p>"
      },
      {
        "id": 55046,
        "text": "<p><span style=\"font-size:12.0pt;\">Internal carotid artery</span></p>"
      },
      {
        "id": 55047,
        "text": "<p><span style=\"font-size:12.0pt;\">Thyrocervical trunk</span></p>"
      },
      {
        "id": 55048,
        "text": "<p><span style=\"font-size:12.0pt;\">Lingual artery</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Inferior thyroid artery is the branch of which of the following? (</span>AIIMS May 2018)</p>",
    "unique_key": "Q8297949",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822827,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Thyrocervical trunk</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The inferior thyroid artery is a branch of the thyrocervical trunk, which is a branch of the subclavian artery's first part. The inferior thyroid artery ascends anterior to the medial border of the scalenus anterior, then turns medially just below the sixth cervical transverse process and descends on longus colli to the thyroid gland's lower border.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/17_0SR9MRp.jpg\" width=\"1070\" height=\"1154\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The relationships between the terminal branches and the recurrent laryngeal nerve are highly variable and have significant surgical implications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. External Carotid Artery</strong>: The external carotid artery supplies most of the structures in the neck, face, scalp, and the upper part of the skull. This artery has several branches, including the superior thyroid, lingual, facial, maxillary, and superficial temporal arteries, among others. While it does supply areas around the thyroid, especially through its superior thyroid branch, it is not the origin of the inferior thyroid artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Internal Carotid Artery</strong>: The internal carotid artery has no branches in the neck. Instead, it moves upward to supply the brain and eyes. It's essential for cerebral circulation and plays a crucial role in supplying blood to the brain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Lingual Artery</strong>: The lingual artery is a branch of the external carotid artery. It supplies the muscles and mucosa of the tongue. Given its role and location, it is not involved in supplying the thyroid gland or associated structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The thyrocervical trunk is a short branch of the subclavian artery, and it supplies numerous structures in the neck. The branches of the thyrocervical trunk are the inferior thyroid artery, the ascending cervical artery, and the transverse cervical artery (which can further divide into superficial and deep branches). The <strong>inferior thyroid artery</strong>, which arises from the thyrocervical trunk, mainly supplies the thyroid and parathyroid glands.</span></p>",
    "correct_choice_id": 55047,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3457,
    "choices": [
      {
        "id": 13807,
        "text": "<p><span style=\"font-size:12.0pt;\">Booster dose of vaccine</span></p>"
      },
      {
        "id": 13808,
        "text": "<p><span style=\"font-size:12.0pt;\">Immunoglobulin with full vaccination</span></p>"
      },
      {
        "id": 13809,
        "text": "<p><span style=\"font-size:12.0pt;\">Repeat full course of vaccine</span></p>"
      },
      {
        "id": 13810,
        "text": "<p><span style=\"font-size:12.0pt;\">No treatment required as he already has Hep B antibody titres from vaccination</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A resident had a needle stick injury while dealing with a Hepatitis B positive patient. Serology was done and HBsAg was negative and the Anti-HBs was &gt;105 mIU/ml. What is the next step of management?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p>",
    "unique_key": "Q8270134",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822673,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) No treatment required as he already has Hep B antibody titres from vaccination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>No treatment required as he already has Hep B antibody titres from vaccination</strong>: The resident's serology shows that HBsAg is negative and Anti-HBs is greater than 105 mIU/ml, which indicates that he has sufficient immunity against Hepatitis B from prior vaccination. No further treatment is necessary because the antibody titres are already protective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Booster dose of vaccine</strong>: Not required since the resident already has sufficient antibody levels indicating immunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Immunoglobulin with full vaccination</strong>: This would be necessary if the resident had low or no detectable antibody titres, indicating no prior immunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Repeat full course of vaccine</strong>: Not necessary because the resident already has adequate antibody titres indicating immunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/23/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_262_page_51.jpg\" alt=\"\" width=\"1000\" height=\"788\"></strong></span></p>",
    "correct_choice_id": 13810,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63638,
    "choices": [
      {
        "id": 253757,
        "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
      },
      {
        "id": 253758,
        "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-c, 3-d, 4-b</span></p>"
      },
      {
        "id": 253759,
        "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-d, 3-a, 4-b</span></p>"
      },
      {
        "id": 253760,
        "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Match the following:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Column A:</strong></span></p><p><span style=\"font-size:16px;\">1. Drugs of Abuse</span></p><p><span style=\"font-size:16px;\">2. On Prescription-only drugs</span></p><p><span style=\"font-size:16px;\">3. Hormones</span></p><p><span style=\"font-size:16px;\">4. Antibiotics</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Column B:</strong></span><br><span style=\"font-size:16px;\">a. Schedule H</span><br><span style=\"font-size:16px;\">b. Schedule G</span><br><span style=\"font-size:16px;\">c. Schedule L</span><br><span style=\"font-size:16px;\">d. Schedule X</span></p>",
    "unique_key": "Q9461334",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822657,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.</strong>&nbsp;<strong>A) 1-d, 2-a, 3-b, 4-c</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Drugs of Abuse \u2013 d. Schedule X:</strong> These include substances with a high potential for abuse and dependency, like narcotics and psychotropic drugs. Special precautions are necessary for storage and prescription.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. On Prescription-only Drugs \u2013 a. Schedule H:</strong> Medications that require a prescription from a Registered Medical Practitioner. These drugs are labeled with a warning and include barbiturates, amphetamines, and sulphonamides.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Hormones \u2013 b. Schedule G:</strong> Schedule G drugs contain hormones or other potent agents that need careful use under medical guidance. Labels include the caution: \u201cDangerous to take without medical supervision.\u201d</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. Antibiotics \u2013 c. Schedule L:</strong> Antibiotics and certain chemotherapeutics are listed under Schedule L. They are also regulated for hospital and medical institution distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Drug Schedules and Associated Categories:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Schedule C</strong>: Encompasses biological products, including items like sera and vaccines.</span></li><li><span style=\"font-size:16px;\"><strong>Schedule E</strong>: Specifies toxic substances used in traditional medicine practices, such as Ayurveda, Siddha, and Unani.</span></li><li><span style=\"font-size:16px;\"><strong>Schedule G</strong>: Covers drugs that are potent and require careful medical oversight, including hormone preparations, antihistamines, and certain anticancer medications.</span></li><li><span style=\"font-size:16px;\"><strong>Schedule H</strong>: Represents prescription-only medications that must display a warning label indicating they are to be sold only with a registered medical practitioner's prescription. This category includes barbiturates, amphetamines, and sulfonamides.</span></li><li><span style=\"font-size:16px;\"><strong>Schedule J</strong>: Lists medications that should not be promoted for treating diseases deemed incurable, such as cancer, cataracts, appendicitis, epilepsy, and others.</span></li><li><span style=\"font-size:16px;\"><strong>Schedule L</strong>: Pertains to antibiotics and chemotherapeutic agents that are regulated similarly to Schedule H drugs, often for use in hospitals and healthcare facilities.</span></li><li><span style=\"font-size:16px;\"><strong>Schedule X</strong>: Involves substances that carry a high risk of abuse and dependency, requiring strict regulation and control.</span></li></ol>",
    "correct_choice_id": 253757,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5751,
    "choices": [
      {
        "id": 22975,
        "text": "<p><span style=\"font-size:12pt;\">0</span></p>"
      },
      {
        "id": 22976,
        "text": "<p><span style=\"font-size:12pt;\">3</span></p>"
      },
      {
        "id": 22977,
        "text": "<p><span style=\"font-size:12pt;\">5</span></p>"
      },
      {
        "id": 22978,
        "text": "<p><span style=\"font-size:12pt;\">8</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A primigravida came to the labor room at 40 weeks + 5 days gestation for induction of labor. On per vaginal examination, the cervix is less then 1 cm dilated and length is 3 cm. The vertex is at -2 station and the cervix is soft and anterior. What will be the bishop score for this lady?&nbsp;(INICET NOV 2017)</span></p>",
    "unique_key": "Q2642705",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822833,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Bishop's score, in this case, is 5.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a scoring system used to assess the favorability of the cervix to respond to induction of labor.</span></li><li><span style=\"font-size:12pt;\">A cervix that is soft in consistency, a little dilated, short in length, anteriorly placed and the station of the presenting low down will respond well to induction of labor.</span></li><li><span style=\"font-size:12pt;\">The Bishop score was replaced by the Modified Bishop score, wherein, the cervical effacement (in terms of percentage) was replaced by cervical length (in cm).</span></li><li><span style=\"font-size:12pt;\">The 5 components of the Modified Bishop score are:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/untitled-294.jpg\" alt=\"\" width=\"500\" height=\"272\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_w6olTxi.png\" width=\"1404\" height=\"355\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The scoring is as shown in the table.</span></li><li><span style=\"font-size:12pt;\">Each component is scored from 0 to 3</span></li><li><span style=\"font-size:12pt;\">The highest score is 13 and the lowest is 0</span></li><li><span style=\"font-size:12pt;\">A favourable score is &gt; 6. This means the patient will respond favorably to methods of induction of labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Bishop score is used to evaluate the readiness of the cervix for induction of labor. A score of 6 or more suggests that the cervix is favorable for induction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 600, DC Dutta\u2019s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 22977,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54326,
    "choices": [
      {
        "id": 216773,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapsone </span></span></span></p>"
      },
      {
        "id": 216774,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ofloxacin </span></span></span></p>"
      },
      {
        "id": 216775,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin </span></span></span></p>"
      },
      {
        "id": 216776,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clofazimine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs used in the treatment of leprosy can result in hyperpigmentation?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q9163017",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822668,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Clofazimine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clofazimine is a drug used in the treatment of leprosy that is known to cause hyperpigmentation as a side effect. This hyperpigmentation can affect the skin, resulting in a reddish-brown to nearly black discoloration. The effect is not limited to the skin; it can also cause discoloration of body fluids such as sweat and urine, potentially leading to staining of clothing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Dapsone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect as Dapsone, while used in leprosy treatment, is not typically associated with hyperpigmentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ofloxacin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect because Ofloxacin, an antibiotic used in some leprosy treatment regimens, does not cause hyperpigmentation as a common side effect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Rifampicin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect as Rifampicin, though it can cause orange-red discoloration of urine and other body fluids, is not associated with skin hyperpigmentation in the way clofazimine is.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clofazimine, a drug used in leprosy treatment, can cause significant hyperpigmentation of the skin and discoloration of body fluids, which can be an important consideration in patient counseling and management.</span></span></span></p>",
    "correct_choice_id": 216776,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 43598,
    "choices": [
      {
        "id": 174055,
        "text": "<p><span style=\"font-size:12.0pt;\">Button battery</span></p>"
      },
      {
        "id": 174056,
        "text": "<p><span style=\"font-size:12.0pt;\">Coin</span></p>"
      },
      {
        "id": 174057,
        "text": "<p><span style=\"font-size:12.0pt;\">Ball</span></p>"
      },
      {
        "id": 174058,
        "text": "<p><span style=\"font-size:12.0pt;\">Bottle cap</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A child presents with breathlessness. On chest X-ray, the following object is seen. Identify? (INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-181303.JPG\" alt=\"\" width=\"300\" height=\"155\"></span></p>",
    "unique_key": "Q5503876",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822821,
    "difficulty_level": "beginner",
    "subjects_id": [
      17
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Button battery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image you\u2019ve provided shows a radiopaque object in the esophagus of a child, which is identified as a button battery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">On X-rays, button batteries typically present as small, circular objects with a double rim or halo effect. This is because they have a distinctive two-layer structure which shows up clearly on radiographs. The appearance in the X-ray&nbsp; is characteristic of a button battery, with a clearly visible double rim. This is a medical emergency due to the risk of rapid and severe damage to the mucosal tissues from electrical discharge and leakage of caustic substances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Coin</strong>: Coins are also circular and radiopaque on X-rays but lack the double rim feature seen with button batteries. Coins tend to be uniform in density throughout. Although they are a common type of foreign body ingested by children, they generally pose less immediate danger compared to button batteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ball</strong>: A small ball, depending on its material, might appear on an X-ray if it's dense enough. However, it would not typically show the structured double rim characteristic of a button battery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Bottle Cap</strong>: Bottle caps may appear circular but would show irregular edges or threading and do not have the double rim appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immediate identification and removal of an ingested button battery are crucial due to the rapid damage that can occur. Emergency endoscopic retrieval is usually necessary to prevent severe injury or death.</span></p>",
    "correct_choice_id": 174055,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10353,
    "choices": [
      {
        "id": 41378,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal BP without pharmacological support</span></p>"
      },
      {
        "id": 41379,
        "text": "<p><span style=\"font-size:12.0pt;\">Positive spinal reflexes on stimulation</span></p>"
      },
      {
        "id": 41380,
        "text": "<p><span style=\"font-size:12.0pt;\">Sweating and tachycardia</span></p>"
      },
      {
        "id": 41381,
        "text": "<p><span style=\"font-size:12.0pt;\">Decorticate and decerebrate posturing</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You have been called to declare the brain death of a 12-year-old child in the ICU. Which of the following is not seen in brain death? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q9353669",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822676,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Decorticate and decerebrate posturing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brain death is defined as the irreversible cessation of all brain activity, including the brainstem. It is a clinical diagnosis based on the absence of neurological function and the irreversible loss of the capacity for consciousness and spontaneous respiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In brain death, the following clinical observations can be present and may be mistakenly interpreted as signs of brainstem function, but they do not indicate any meaningful brain activity:</span></p><p>&nbsp;</p><p>Things That Can Be Present in Brain Death-&nbsp;</p><ol><li>Normal blood pressure without drugs</li><li>Spinal reflexes<ol><li>Movements like Babinski, deep tendon reflexes may be seen.</li><li>These come from the spinal cord, not the brain</li></ol></li><li>Sweating or tachycardia<ol><li>Autonomic responses \u2014 do not indicate brain activity.</li></ol></li><li>What is Not Seen in Brain Death:<ol><li>Decorticate or decerebrate posturing<ol><li>These need some brain activity</li><li>In brain death: no such posturing happens \u2014 total motor silence.<br><br><br>&nbsp;</li></ol></li></ol></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">However, <strong>decorticate and decerebrate posturing</strong> are not seen in brain death. These postures are indicative of severe brain injury but require some level of brain activity to generate the motor response. In brain death, all brain-originating motor responses, including these postures, are absent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Normal BP without pharmacological support:</strong> Autonomic responses may still maintain blood pressure without brain function, making this observation consistent with brain death.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Positive spinal reflexes on stimulation:</strong> These reflexes are mediated by the spinal cord, not the brain, and thus can still occur in brain death.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sweating and tachycardia:</strong> These autonomic functions can persist despite brain death due to residual autonomic nervous system activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brain death is characterized by the complete absence of brain-originating motor responses, including decorticate and decerebrate posturing, despite possible preservation of autonomic functions like normal BP and spinal reflexes.</span></p>",
    "correct_choice_id": 41381,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74680,
    "choices": [
      {
        "id": 297633,
        "text": "<p><span style=\"font-size:16px;\">Bimanual compression</span></p>"
      },
      {
        "id": 297634,
        "text": "<p><span style=\"font-size:16px;\">Uterine massage</span></p>"
      },
      {
        "id": 297635,
        "text": "<p><span style=\"font-size:16px;\">CCT</span></p>"
      },
      {
        "id": 297636,
        "text": "<p><span style=\"font-size:16px;\">Administration of oxytocics</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which step is not included in active management of third stage of labor (AMTSL)? (INICET NOV 2024)</span></p>",
    "unique_key": "Q1898338",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822838,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Bimanual compression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Active Management of Third Stage of Labor (AMTSL) consists of three basic components as defined by WHO in the early 2000s:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Administration of oxytocics (primarily oxytocin)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Controlled Cord Traction (CCT)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Uterine massage (now termed as postpartum vigilance)</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">An additional component that has been recently added is <strong>delayed cord clamping</strong>, though this is primarily for preventing neonatal anemia rather than preventing postpartum hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>B. Uterine massage:&nbsp;</strong>Uterine massage is a core component of AMTSL. While the terminology has evolved to \"<strong>postpartum vigilance,</strong>\" it remains an essential step where the uterus is checked and massaged if not well contracted.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>C. CCT (Controlled Cord Traction):&nbsp;</strong>CCT is one of the three basic steps of AMTSL.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>D. Administration of oxytocics:&nbsp;</strong>Administration of oxytocics, particularly oxytocin, is the first and crucial step of AMTSL.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Bimanual compression is a treatment method for atonic postpartum hemorrhage, not a preventive measure in AMTSL. The three basic components of AMTSL are: <strong>administration of oxytocics, controlled cord traction, and uterine massage/postpartum vigilance.</strong></span></p>",
    "correct_choice_id": 297633,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 76128,
    "choices": [
      {
        "id": 303385,
        "text": "<p><span style=\"font-size:18px;\">Injecting drug users (IDU)</span></p>"
      },
      {
        "id": 303386,
        "text": "<p><span style=\"font-size:18px;\">Men having sex with men (MSM)</span></p>"
      },
      {
        "id": 303387,
        "text": "<p><span style=\"font-size:18px;\">Commercial sex workers (CSW)</span></p>"
      },
      {
        "id": 303388,
        "text": "<p><span style=\"font-size:18px;\">Long distance truck drivers (LDTD)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which of the following is not a high risk group for HIV? </strong><i><strong>[INICET NOV 2024]</strong></i></span></p>",
    "unique_key": "Q5174164",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822855,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Long distance truck drivers (LDTD)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">High-risk groups for HIV are populations that have <strong>both high risk and high prevalence of HIV.</strong>&nbsp;</span></li><li><span style=\"font-size:18px;\">According to the National AIDS Control Program's epidemiological classification, high-risk groups include <strong>commercial sex workers, injecting drug users, men having sex with men, and transgenders.</strong>&nbsp;</span></li><li><span style=\"font-size:18px;\">These groups have the highest risk of contracting and transmitting HIV due to their behaviors or circumstances.</span></li><li><span style=\"font-size:18px;\"><strong>Long distance truck drivers are classified as a bridge population, not a high-risk group</strong>.&nbsp;</span></li><li><span style=\"font-size:18px;\">Bridge populations are those who contract HIV because they come in contact with the high-risk groups, and then potentially transmit it to the general population.&nbsp;</span></li><li><span style=\"font-size:18px;\"><strong>Along with truck drivers, bridge populations include migrant laborers, partners of IDUs, clients of commercial sex workers, and populations in conflict areas.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>HIV Transmission Spectrum: High-Risk Groups vs Bridge Populations vs General Populations</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mH409b4.png\" width=\"1044\" height=\"342\"></strong></span></p>",
    "correct_choice_id": 303388,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 472,
    "choices": [
      {
        "id": 1884,
        "text": "<p>1</p>"
      },
      {
        "id": 1885,
        "text": "<p>7</p>"
      },
      {
        "id": 1886,
        "text": "<p>9</p>"
      },
      {
        "id": 1887,
        "text": "<p>4</p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient came with complaints of inability to move his 4th and 5th digit, cannot hold a pen and he was not able to hold a paper between fingers. Which of the following sites given below is the probable cause of injury to the nerve in question? (</span>AIIMS Nov 2017)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-23.jpg\" alt=\"\" width=\"200\" height=\"324\"></span></p>",
    "unique_key": "Q7106479",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822828,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 7</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of a patient complaining of inability to move his 4<sup>th</sup> and 5<sup>th</sup> digit, not able to hold a pen and also not able to hold paper between fingers, all together suggests towards an ulnar nerve injury. The most likely site of injury would thus be medial epicondyle \u2013 structure marked as 7.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Given below is the labelling of the structures marked in the figure -</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Head</span></li><li><span style=\"font-size:12.0pt;\">Greater Tubercle</span></li><li><span style=\"font-size:12.0pt;\">Intertubercular Groove</span></li><li><span style=\"font-size:12.0pt;\">Deltoid Tuberosity</span></li><li><span style=\"font-size:12.0pt;\">Capitulum</span></li><li><span style=\"font-size:12.0pt;\">Trochlea</span></li><li><span style=\"font-size:12.0pt;\">Medial Epicondyle</span></li><li><span style=\"font-size:12.0pt;\">Olecranon Fossa</span></li><li><span style=\"font-size:12.0pt;\">Lateral Epicondyle</span></li><li><span style=\"font-size:12.0pt;\">Lesser Tubercle</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1: Head of Humerus:</strong> This area is not typically associated with isolated ulnar nerve injuries. Injuries here affect the axillary nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 9: Lateral Epicondyle:</strong> The lateral epicondyle is more commonly associated with injuries affecting the radial nerve or conditions like lateral epicondylitis (tennis elbow).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 4: Deltoid Tuberosity:</strong> This site on the humerus is typically associated with the attachment of the deltoid muscle. Injuries or issues here would more likely affect the deltoid muscle or the radial nerve dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tests for ulnar nerve lesions are as follows:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Card Test</strong>: This isn't a widely recognized test in the context of ulnar nerve pathology. However, in some practices, the card test might refer to asking the patient to hold a card (like a credit card) between their thumb and the side of their index finger. Difficulty or inability to do this due to a weak adductor pollicis muscle (innervated by the ulnar nerve) may suggest ulnar nerve dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Claw Hand Deformity</strong>: This is seen in ulnar nerve injuries. In a typical ulnar claw hand, the 4th and 5th digits (ring and little fingers) are hyperextended at the metacarpophalangeal (MCP) joints and flexed at the interphalangeal (IP) joints. This occurs due to the loss of function of the lumbricals and interossei of the hand, which are innervated by the ulnar nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Froment's Sign</strong>: This is a classic sign of ulnar nerve palsy. The patient is asked to hold a piece of paper between their thumb and the side of their index finger (pinch grip). If the ulnar nerve is compromised, the patient will compensate by flexing the thumb's IP joint to maintain grip strength, which is a positive Froment's sign. This indicates weakness or paralysis of the adductor pollicis muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Wartenberg Sign</strong>: In ulnar nerve injury, there's unopposed action of the extensor digiti minimi, which leads to abduction of the little finger. The patient will be unable to bring their little finger back to the side of the hand, leading to the \"Wartenberg sign.\"</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>5. Palmaris Brevis Sign</strong>: This is a sign of ulnar nerve functionality. The palmaris brevis muscle is innervated by the ulnar nerve. Upon tapping or massaging the hypothenar eminence (palm side of the hand, base of the little finger), contraction of the palmaris brevis muscle can be observed as a twitching or dimpling. If present, it indicates that at least part of the ulnar nerve's function remains intact.</span></p>",
    "correct_choice_id": 1885,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13042,
    "choices": [
      {
        "id": 52130,
        "text": "<p><span style=\"font-size:12.0pt;\">Novus actus interveniens</span></p>"
      },
      {
        "id": 52131,
        "text": "<p><span style=\"font-size:12.0pt;\">Res ipsa loquitur</span></p>"
      },
      {
        "id": 52132,
        "text": "<p><span style=\"font-size:12.0pt;\">Res judicata&nbsp;</span></p>"
      },
      {
        "id": 52133,
        "text": "<p><span style=\"font-size:12.0pt;\">Vicarious liability</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 50-year-old lady underwent a total abdominal hysterectomy. She came to the hospital after one week with acute pain in the abdomen with features suggestive of perforation. An X-ray showed the following picture. Identify the type of offense for which the surgeon can be held responsible? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-38.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p>",
    "unique_key": "Q1606412",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822824,
    "difficulty_level": "beginner",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Res ipsa loquitur</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The X-ray indicates surgical scissors accidentally left behind during surgery.</span></li><li><span style=\"font-size:12.0pt;\">The surgeon can be held guilty for Res ipsa loquitur.</span></li><li><span style=\"font-size:12.0pt;\">\"Res ipsa loquitur\" means \"the thing or fact speaks for itself.\"</span></li><li><span style=\"font-size:12.0pt;\">The negligent act by the doctor is obvious from the Xray and the patient need not prove the negligence.</span></li><li><span style=\"font-size:12.0pt;\">Conditions to be fulfilled to prove negligence:</span></li><li><span style=\"font-size:12.0pt;\">In the absence of negligence, there would not have been any injury usually</span></li><li><span style=\"font-size:12.0pt;\">The doctor had complete control over the injury-producing instrument or treatment.</span></li><li><span style=\"font-size:12.0pt;\">There was no contributory negligence from the patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Novus actus interveniens:</strong> Refers to a new intervening act that breaks the chain of causation. It is not applicable here as the negligence was directly related to the surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Res judicata:</strong> Refers to a matter that has been adjudicated by a competent court and therefore cannot be pursued further by the same parties. It is not relevant to the context of proving negligence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vicarious liability:</strong> Refers to the liability of one party for the actions of another, typically an employer for an employee. This does not directly apply to the surgeon's individual negligence in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of surgical instruments left inside a patient post-operation is a clear case of negligence, aptly described by the legal principle of \"Res ipsa loquitur,\" meaning the fact speaks for itself.</span></p>",
    "correct_choice_id": 52131,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5800,
    "choices": [
      {
        "id": 23171,
        "text": "<p><span style=\"font-size:12pt;\">FSH</span></p>"
      },
      {
        "id": 23172,
        "text": "<p><span style=\"font-size:12pt;\">Estrogen</span></p>"
      },
      {
        "id": 23173,
        "text": "<p><span style=\"font-size:12pt;\">LH</span></p>"
      },
      {
        "id": 23174,
        "text": "<p><span style=\"font-size:12pt;\">Progesterone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following hormones will be secreted in high amounts by the ovarian granulosa cells during the follicular phase of the menstrual cycle?&nbsp;</span>(INICET MAY 2018)</p>",
    "unique_key": "Q5442340",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822822,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Estrogen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During the follicular phase of the menstrual cycle, the granulosa cells of the developing follicles secrete high amounts of estrogen, specifically estradiol. This phase is characterized by the development of a primordial follicle to the Graafian stage, with atresia of neighboring follicles. The following events occur during this phase:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Estrogen Secretion:</strong> Granulosa cells secrete increasing amounts of estrogen, primarily estradiol, which causes proliferation of the endometrium in preparation for potential implantation.</span></li><li><span style=\"font-size:12pt;\"><strong>Up-regulation of Receptors:</strong> LH and FSH receptors are up-regulated in both theca and granulosa cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Feedback Mechanism:</strong> The rising estradiol levels exert a negative feedback effect on the anterior pituitary, suppressing the secretion of FSH and LH to moderate levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. FSH (Follicle Stimulating Hormone):</strong> FSH is secreted by the anterior pituitary gland and stimulates the growth of ovarian follicles but is not secreted by granulosa cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. LH (Luteinizing Hormone):</strong> LH is also secreted by the anterior pituitary and plays a role in the later stages of follicle development and ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Progesterone:</strong> Progesterone is primarily secreted by the corpus luteum after ovulation during the luteal phase of the menstrual cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During the follicular phase of the menstrual cycle, ovarian granulosa cells secrete high amounts of estrogen, which is crucial for the proliferation of the endometrium and regulation of FSH and LH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 78, DC Dutta\u2019s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 23172,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4505,
    "choices": [
      {
        "id": 17996,
        "text": "<p><span style=\"color:black;font-size:12pt;\">IV adenosine</span></p>"
      },
      {
        "id": 17997,
        "text": "<p><span style=\"font-size:12pt;\">IV diltiazem</span></p>"
      },
      {
        "id": 17998,
        "text": "<p><span style=\"font-size:12pt;\">DC cardioversion</span></p>"
      },
      {
        "id": 17999,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Ibutilide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 50-year-old patient with a history of hypertension and diabetes mellitus developed the following rhythm. His blood pressure was 70/40 mm Hg and he had a feeble pulse.&nbsp;What is the next step of management? (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1_6DETd4g.jpg\" alt=\"\" width=\"300\" height=\"120\"></span></p>",
    "unique_key": "Q7998684",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822651,
    "difficulty_level": "beginner",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) DC cardioversion</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The ECG shows supraventricular tachycardia (SVT).</span></li><li><span style=\"font-size:12pt;\">The patient is also hemodynamically unstable, as indicated by the low blood pressure (70/40 mm Hg) and feeble pulse.</span></li><li><span style=\"font-size:12pt;\">When a patient presents with SVT and hemodynamic instability, immediate rhythm conversion is essential.</span></li><li><span style=\"font-size:12pt;\">The recommended treatment in such cases is direct current (DC) cardioversion.</span></li><li><span style=\"font-size:12pt;\">This involves delivering an electric shock to the heart to restore a normal rhythm and stabilize the patient's hemodynamic status.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. IV adenosine:&nbsp;</strong>Adenosine temporarily slows or stops the heart's electrical activity and is often the first-line treatment for terminating stable, narrow complex supraventricular tachycardias (SVT). However, in hemodynamically unstable patients, its short-lived effects make it less suitable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. IV diltiazem:&nbsp;</strong>Diltiazem is a calcium channel blocker used to control the rate in atrial fibrillation or flutter and certain types of SVT. In hemodynamically unstable patients, slowing the heart rate without converting the rhythm can be dangerous.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ibutilide:&nbsp;</strong>Ibutilide is an antiarrhythmic drug used to treat certain types of atrial fibrillation or flutter. It's not the first-line treatment for hemodynamically unstable SVT and carries a risk of proarrhythmia, meaning it can sometimes cause new or worsening rhythm problems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For patients with supraventricular tachycardia (SVT) and hemodynamic instability, direct current (DC) cardioversion is the recommended and most effective treatment.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Ref: Miller\u2019s Anesthesia, 9<sup>th</sup> Ed. Pg</strong></span><span style=\"font-size:12pt;\"> <strong>1744</strong></span></p>",
    "correct_choice_id": 17998,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11078,
    "choices": [
      {
        "id": 44278,
        "text": "<p><span style=\"font-size:18px;\">LAQSHYA</span></p>"
      },
      {
        "id": 44279,
        "text": "<p><span style=\"font-size:18px;\">Ayushman Bharat</span></p>"
      },
      {
        "id": 44280,
        "text": "<p><span style=\"font-size:18px;\">Janani Shishu Suraksha Karyakram</span></p>"
      },
      {
        "id": 44281,
        "text": "<p><span style=\"font-size:18px;\">Pradhan Mantri Surakshit Matritva Abhiyan</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>As a healthcare consultant in Uttar Pradesh working to improve maternal and child health outcomes, you need to address issues such as inadequate hygiene, lack of skilled staff, and outdated equipment in labor rooms of public health facilities. Which program should you recommend that is specifically designed to enhance the quality of labor rooms? </strong><i><strong>[AIIMS MAY 2019]</strong></i></span></p>",
    "unique_key": "Q3076361",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822674,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) LAQSHYA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">LAQSHYA [<strong>La</strong>bour Room <strong>Q</strong>uality Improvement Initiative]&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">MoHFW launched LaQshya to improve the quality of care that is being provided to the pregnant mother in the Labor Room and Maternity Operation Theaters, thereby preventing the undesirable adverse outcomes associated with childbirth</span></li><li><span style=\"font-size:18px;\">Aim: To reduce Maternal and newborn mortality &amp; morbidity and stillbirths</span></li><li><span style=\"font-size:18px;\">Coverage: Govt Medical colleges &amp; hospitals/District hospitals/FRU &gt; 100 deliveries/month, High load CHC (&gt;60 deliveries/month)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture12.jpg\" alt=\"\" width=\"500\" height=\"642\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Ayushman Bharat</strong>: This is a broader health insurance scheme aimed at providing health cover to underprivileged families, not specifically focused on improving labor room conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Janani Shishu Suraksha Karyakram</strong>: Although this program provides free benefits to pregnant women and sick infants, it does not specifically target the improvement of labor room conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Pradhan Mantri Surakshit Matritva Abhiyan</strong>: This initiative is aimed at providing assured, comprehensive, and quality antenatal care, free of cost, to pregnant women on the 9th of every month but does not specifically address labor room quality improvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Recommending the LAQSHYA program is directly aligned with the need to overhaul the quality of labor rooms in public health facilities, targeting specific improvements in infrastructure, hygiene, and staff competencies to ensure safer childbirth experiences.</span></li></ul>",
    "correct_choice_id": 44278,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4497,
    "choices": [
      {
        "id": 17964,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Exercise ECG testing</span></p>"
      },
      {
        "id": 17965,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Dobutamine stress echocardiography</span></p>"
      },
      {
        "id": 17966,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Myocardial perfusion scintigraphy</span></p>"
      },
      {
        "id": 17967,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Coronary angiography</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following non-invasive investigations provides the most accurate prognostic information with respect to predicting risks of perioperative cardiac complications? (NEET PG 2020)</span></p>",
    "unique_key": "Q8106037",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822649,
    "difficulty_level": "beginner",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Dobutamine stress echocardiography</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is an echocardiogram that is performed while the heart is under the stress of increased workload. If a patient cannot exercise, a drug called dobutamine is administered to simulate the effects of exercise on the heart.</span></li><li><span style=\"font-size:12pt;\">The test helps identify areas of the heart that may not be receiving enough blood due to blockages in the coronary arteries. A significant change in the motion of the heart wall during the test is a strong predictor of perioperative cardiac complications, making this test highly valuable in the mentioned context.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Exercise ECG testing:&nbsp;</strong>Exercise ECG testing, also known as exercise stress testing or treadmill testing, involves the patient exercising on a treadmill or stationary bicycle while their heart rate, blood pressure, and electrocardiogram (ECG) are monitored. The purpose is to determine how the heart responds to the stress of exercise. Abnormal changes in the ECG during or after exercise may suggest coronary artery disease (CAD). While this test can indicate the presence of CAD, it does not specifically predict perioperative cardiac complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Myocardial perfusion scintigraphy:&nbsp;</strong>Also known as a nuclear stress test, this investigation involves injecting a small amount of radioactive substance into the patient and using a special camera to visualize how blood flows through the heart muscle, both at rest and during stress (either exercise or with a medication). This test can identify areas of the heart that aren't getting enough blood, indicative of CAD. While it can detect and evaluate the severity of CAD, it's less specific than dobutamine stress echocardiography in predicting perioperative cardiac complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Coronary angiography:&nbsp;</strong>This is a procedure in which a contrast dye is injected into the coronary arteries, and X-rays are taken to visualize the flow of blood through these arteries. It is used to directly visualize blockages in the coronary arteries. As the \"gold standard\" for diagnosing CAD, coronary angiography can provide detailed information about the location and severity of blockages. However, it's an invasive procedure, involving threading a catheter through the blood vessels to the heart, and carries risks such as bleeding, allergic reactions, or kidney damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Dobutamine stress echocardiography is the most accurate non-invasive investigation for predicting perioperative cardiac complications due to its ability to simulate exercise and identify areas of the heart with reduced blood flow.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Ref: Miller\u2019s Anesthesia, 9<sup>th</sup> Ed. Pg</strong></span><span style=\"font-size:12pt;\"> <strong>935</strong></span></p>",
    "correct_choice_id": 17965,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4508,
    "choices": [
      {
        "id": 18008,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Physostigmine</span></p>"
      },
      {
        "id": 18009,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Neostigmine</span></p>"
      },
      {
        "id": 18010,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Carbachol</span></p>"
      },
      {
        "id": 18011,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Succinylcholine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient is given a nicotinic receptor antagonist as a muscle relaxant. Which drug is given postoperatively to recover from muscle weakness? (NEET PG 2020)</span></p>",
    "unique_key": "Q4269626",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822652,
    "difficulty_level": "beginner",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Neostigmine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For reversal of neuromuscular blockade from non-depolarizing muscle relaxants, the reversal agent of choice is Neostigmine.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Neostigmine is a cholinesterase inhibitor that boosts the concentration of acetylcholine in the neuromuscular junction, thus enhancing muscle contraction.</span></li><li><span style=\"font-size:12.0pt;\">Neostigmine is the drug of choice for reversing the effects of non-depolarizing muscle relaxants postoperatively. By preventing the breakdown of acetylcholine, it counteracts the muscle-relaxing effects of these drugs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Physostigmine:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Physostigmine is a reversible cholinesterase inhibitor. It increases the concentration of acetylcholine at nerve endings.</span></li><li><span style=\"font-size:12.0pt;\">Physostigmine is primarily used to treat anticholinergic (atropine-like) drug overdoses. It can cross the blood-brain barrier and is used for central anticholinergic syndromes. It is not typically used for reversing neuromuscular blockade from muscle relaxants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbachol:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Carbachol is a cholinergic drug that acts as an agonist at both muscarinic and nicotinic receptors.</span></li><li><span style=\"font-size:12.0pt;\">Carbachol is primarily used in ophthalmology to induce miosis or to reduce intraocular pressure. It is not used for reversing neuromuscular blockade.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Succinylcholine:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Succinylcholine is a depolarizing neuromuscular blocker. It binds to nicotinic receptors and causes prolonged depolarization, which initially causes muscle fasciculation followed by paralysis.</span></li><li><span style=\"font-size:12.0pt;\">Succinylcholine itself causes muscle paralysis and is used to facilitate intubation during anesthesia induction. It would not be used to reverse muscle relaxation; in fact, it would exacerbate it.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neostigmine is the preferred agent for reversing the effects of non-depolarizing muscle relaxants postoperatively.</span></p>",
    "correct_choice_id": 18009,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 444,
    "choices": [
      {
        "id": 1772,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture8_F5dFVCm.jpg\" alt=\"\" width=\"300\" height=\"188\"></p>"
      },
      {
        "id": 1773,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture9.jpg\" alt=\"\" width=\"250\" height=\"360\"></p>"
      },
      {
        "id": 1774,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture10.jpg\" alt=\"\" width=\"300\" height=\"204\"></p>"
      },
      {
        "id": 1775,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture11.jpg\" alt=\"\" width=\"300\" height=\"291\"></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following represents a holocrine gland? (</span>AIIMS Nov 2017)</p>",
    "unique_key": "Q2112738",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822671,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The histopathological image marked 'B' represents the sebaceous gland, which is a type of holocrine gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-92.jpg\" alt=\"\" width=\"250\" height=\"333\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options A: Image A.&nbsp;</strong>Sweat glands - Eccrine/merocrine glands; glands remain intact</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-93.jpg\" alt=\"\" width=\"500\" height=\"302\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options C: Image C.&nbsp;</strong>Mammary gland - Apocrine gland; apical part sheds to secrete</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-94.jpg\" alt=\"\" width=\"300\" height=\"217\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Image D.&nbsp;</strong>Ceruminous gland - Apocrine glands</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-95.jpg\" alt=\"\" width=\"300\" height=\"304\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Holocrine secretions are produced in the cytoplasm of the cell and released by the rupture of the plasma membrane, which destroys the cell and results in the secretion of the product into the lumen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Examples of holocrine glands are: -</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Sebaceous glands of the skin and</span></li><li><span style=\"font-size:12.0pt;\">Meibomian glands of the eyelid</span></li></ul>",
    "correct_choice_id": 1773,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24690,
    "choices": [
      {
        "id": 98721,
        "text": "<p><span style=\"font-size:12.0pt;\">Aspergillus</span></p>"
      },
      {
        "id": 98722,
        "text": "<p><span style=\"font-size:12.0pt;\">Mucor</span></p>"
      },
      {
        "id": 98723,
        "text": "<p><span style=\"font-size:12.0pt;\">Talaromyces</span></p>"
      },
      {
        "id": 98724,
        "text": "<p><span style=\"font-size:12.0pt;\">Blastomyces</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the organism in the given image. (INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125651.jpg\" alt=\"\" width=\"300\" height=\"212\"></span></p>",
    "unique_key": "Q1098940",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822662,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mucor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histopathological staining shows broad septate, hyaline hyphae with wide angle branching, which suggests that it is more likely Mucor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/untitled-1.jpg\" alt=\"\" width=\"1000\" height=\"1464\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspergillus:</strong> Aspergillus shows aseptate narrow hyphae with acute angle branching.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Talaromyces:</strong> Talaromyces is a genus of fungi that forms septate hyphae and conidiophores.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Blastomyces:</strong> Blastomyces dermatitidis is a dimorphic fungus that appears as broad-based budding yeast in tissue sections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mucor is identified by broad aseptate hyaline hyphae with wide-angle branching, and it typically lacks rhizoids, unlike Rhizopus which has nodal rhizoids.</span></p>",
    "correct_choice_id": 98722,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13961,
    "choices": [
      {
        "id": 55805,
        "text": "<p><span style=\"font-size:12.0pt;\">Epidermis</span></p>"
      },
      {
        "id": 55806,
        "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous tissue</span></p>"
      },
      {
        "id": 55807,
        "text": "<p><span style=\"font-size:12.0pt;\">Papillary dermis</span></p>"
      },
      {
        "id": 55808,
        "text": "<p><span style=\"font-size:12.0pt;\">Reticular dermis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following layers is involved in blister formation in a superficial partial thickness burn? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q1953753",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822832,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Papillary dermis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The papillary dermis is a layer of the skin that lies just below the epidermis. Blister formation in superficial partial thickness burns occurs within this layer, as it is the point where the burn has affected both the epidermis and the upper portion of the dermis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Epidermis</strong>: The epidermis is the outermost layer of the skin. In superficial partial thickness burns, this layer is typically damaged, but blister formation occurs slightly deeper within the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Subcutaneous tissue</strong>: The subcutaneous tissue is located beneath the dermis and is not typically involved in blister formation in superficial partial thickness burns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Reticular dermis</strong>: The reticular dermis is located deeper in the skin and is not primarily associated with blister formation in superficial partial thickness burns. Blister formation occurs closer to the surface.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The papillary dermis is involved in blister formation in a superficial partial-thickness burn.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>First-degree burns&nbsp;</strong>involve only the epidermis, with pain, redness, and mild swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Second-degree burns&nbsp;</strong>involve the epidermis and some parts of the dermis (also known as partial-thickness burns). Further classified as-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Superficial second degree or superficial partial-thickness burn - involves the upper part of the dermis (papillary) and shows pain, blisters, and severe swelling.</span></li><li><span style=\"font-size:12.0pt;\">Deep second degree or deep partial-thickness burn - extends deeper up to the reticular layer of the dermis and appears paler and more mottled, does not blanch to touch, but remains painful to pinprick.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Third-degree or full-thickness burns&nbsp;</strong>involve the complete thickness of the dermis and subcutaneous tissue.</span></p>",
    "correct_choice_id": 55807,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11184,
    "choices": [
      {
        "id": 44702,
        "text": "<p><span style=\"font-size:18px;\">Decrease in incidence</span></p>"
      },
      {
        "id": 44703,
        "text": "<p><span style=\"font-size:18px;\">Decrease in prevalence</span></p>"
      },
      {
        "id": 44704,
        "text": "<p><span style=\"font-size:18px;\">Increase in incidence</span></p>"
      },
      {
        "id": 44705,
        "text": "<p><span style=\"font-size:18px;\">Increase in prevalence</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Imagine a scenario where a novel medication is introduced that significantly reduces mortality from a specific disease but does not actually cure the disease. As patients continue to live longer with the disease due to this medication, it would have an effect on the epidemiological metrics. Which of the following statements correctly describes the expected change in prevalence and incidence as a result of this medication? </strong><i><strong>[INICET NOV 2021]</strong></i></span></p>",
    "unique_key": "Q6717688",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822846,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Increase in prevalence</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The given scenario shows that there is a drug which can reduce mortality but cannot cure a particular disease.</span></li><li><span style=\"font-size:18px;\">So, old cases will live longer and thus, there will be increase in prevalence. Incidence will not get affected due to this.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Decrease in incidence</strong>: Incorrect, as the medication does not affect the rate at which new cases occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Decrease in prevalence</strong>: Incorrect, since patients living longer with the disease will increase prevalence.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Increase in incidence</strong>: Incorrect, because incidence measures new cases, not the duration or survival of existing cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>PREVALENCE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Total current (Old + New) cases in a given population over.</span></li><li><span style=\"font-size:18px;\">Prevalence = Incidence \u00d7 Mean duration of disease [P = I \u00d7 d]</span></li><li><span style=\"font-size:18px;\">Prevalence describes the balance between incidence, mortality and recovery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>INCIDENCE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Number of new cases occurring in a defined population over a specified period of time.</span></li></ul>",
    "correct_choice_id": 44705,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9838,
    "choices": [
      {
        "id": 39319,
        "text": "<p><span style=\"font-size:12.0pt;\">Asbestosis</span></p>"
      },
      {
        "id": 39320,
        "text": "<p><span style=\"font-size:12.0pt;\">Silicosis</span></p>"
      },
      {
        "id": 39321,
        "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
      },
      {
        "id": 39322,
        "text": "<p><span style=\"font-size:12.0pt;\">Mesothelioma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient working in a factory presented with lung fibrosis and thickening of pleura.&nbsp;Biopsy was done. Diagnosis from the histopathology picture is?</span> (AIIMS MAY 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/965.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p>",
    "unique_key": "Q4008117",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822861,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Asbestosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This clinical scenario and image showing typical asbestos bodies are suggestive of asbestosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Asbestosis is a type of pneumoconiosis associated with asbestos exposure. The disease-causing capabilities of the different forms of asbestos depend on concentration, size, shape, and solubility. This condition is <strong>marked by diffuse pulmonary interstitial fibrosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Grossly</strong>, the affected lungs are small and firm with <strong>cartilage-like thickening of the pleura</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:11pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-123503.png\" alt=\"\" width=\"600\" height=\"220\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The sectioned surface shows variable degree of pulmonary fibrosis, especially in the<strong> </strong>advanced cases may show cystic changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Histologically, the following changes are observed:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Non-specific interstitial fibrosis.</span></li><li><span style=\"font-size:12.0pt;\">Presence of characteristic <strong>asbestos bodies</strong> - asbestos fibres coated with glycoprotein and hemosiderin and appear beaded or dumbbell-shaped. The coating <strong>stains positively for Prussian blue reaction.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note: Asbestos exposure is associated with malignant mesothelioma, </strong>a rare and aggressive cancer of the pleura.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-123702.png\" alt=\"\" width=\"1000\" height=\"213\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-115000.png\" alt=\"\" width=\"400\" height=\"192\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Microscopic appearance</strong> of asbestos body. An asbestos body is an asbestos fibre coated with glycoprotein and hemosiderin giving it beaded or dumbbell \u2013 shaped appearance with bulbous ends.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Silicosis</strong>: Another type of pneumoconiosis caused by inhalation of silica dust, but it does not produce asbestos bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tuberculosis</strong>: An infectious disease primarily caused by Mycobacterium tuberculosis, characterized by granulomas and caseating necrosis, not by the presence of asbestos bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mesothelioma</strong>: While asbestos exposure is a risk factor for mesothelioma, the histological appearance in this case is more indicative of asbestosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Asbestosis&nbsp;</strong>is identified by the presence of characteristic <strong>asbestos bodies</strong> within the lung tissue, which are asbestos fibers coated with glycoproteins and hemosiderin, and it is commonly associated with <strong>asbestos exposure</strong> in occupational settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease 8<sup>th</sup> edition pg 1309</strong></span></p>",
    "correct_choice_id": 39319,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7050,
    "choices": [
      {
        "id": 28168,
        "text": "<p><span style=\"font-size:12.0pt;\">Adequate safety profile needs to be established</span></p>"
      },
      {
        "id": 28169,
        "text": "<p><span style=\"font-size:12.0pt;\">Cost to benefit has to be considered</span></p>"
      },
      {
        "id": 28170,
        "text": "<p><span style=\"font-size:12.0pt;\">Fixed dose combination of drugs is preferred over single drugs</span></p>"
      },
      {
        "id": 28171,
        "text": "<p><span style=\"font-size:12.0pt;\">Disease prevalence is considered</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is false about the selection of essential drugs? (INICET MAY 2021)</span></p>",
    "unique_key": "Q8002091",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822852,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Fixed dose combination of drugs is preferred over single drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO has defined Essential Medicines (Drugs) as \u201cthose that satisfy the priority healthcare needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times and in adequate amounts, in appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford.\u201d</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is generally false. While fixed-dose combinations (FDCs) can be beneficial in certain scenarios (like in the treatment of HIV/AIDS or tuberculosis), they are not universally preferred over single-drug formulations. The preference for FDCs or single drugs depends on several factors, including the therapeutic context, the risk of drug-drug interactions, patient adherence, and the potential for resistance development. Mostly, single drugs are preferred due to their flexibility in dosing and the ability to adjust individual components based on patient needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Adequate safety profile needs to be established</strong>: This is true. When selecting essential drugs, it's crucial that they have a well-established safety profile. Safety is a key consideration to ensure that the benefits of a drug outweigh its risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cost to benefit has to be considered</strong>: This is also true. In the selection of essential drugs, the cost-effectiveness of a drug is an important factor. The aim is to provide the most effective treatment at the lowest possible cost.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Disease prevalence is considered</strong>: This is true. When selecting essential drugs, the prevalence of diseases in a population is an important consideration. Drugs to treat common and life-threatening diseases are typically prioritized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The selection of essential drugs prioritizes factors like safety, cost-effectiveness, and disease prevalence. Fixed-dose combinations are not universally preferred over single drugs, as the choice depends on specific therapeutic needs and other considerations.</span></p>",
    "correct_choice_id": 28170,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14409,
    "choices": [
      {
        "id": 57597,
        "text": "<p><span style=\"font-size:12.0pt;\">Rough handling of thyroid during surgery</span></p>"
      },
      {
        "id": 57598,
        "text": "<p><span style=\"font-size:12.0pt;\">Due to parathyroid gland</span></p>"
      },
      {
        "id": 57599,
        "text": "<p><span style=\"font-size:12.0pt;\">Inadequate patient preparation</span></p>"
      },
      {
        "id": 57600,
        "text": "<p><span style=\"font-size:12.0pt;\">Infections</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 46-year-old female is undergoing thyroidectomy for a large goiter. During the procedure, the patient develops tachycardia, hypertension, and hyperthermia. She becomes agitated and confused. Laboratory tests reveal elevated thyroid hormone levels, and a diagnosis of thyroid storm is made. The surgical team immediately stops the procedure, and the patient is transferred to the intensive care unit for treatment. What is the most common cause of thyroid storm during thyroidectomy? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q9883099",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822658,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Inadequate patient preparation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Inadequate preparation of a patient with hyperthyroidism before thyroidectomy, such as not optimizing thyroid function and medication management, can increase the risk of thyroid storm. Proper preoperative management and stabilization of thyroid function are crucial to prevent this complication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Rough handling of thyroid during</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>surgery</strong>: While rough handling during thyroid surgery can potentially lead to complications, it is not the usual cause of thyroid storm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Due to parathyroid gland</strong> <strong>injury</strong>: The parathyroid glands are separate from the thyroid gland and regulate calcium levels in the body. Complications involving the parathyroid glands can occur during thyroid surgery leading to postoperative hypocalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Infections</strong>: Infections can occur as complications after thyroid surgery, but they are not the usual cause of thyroid storm. Thyroid storm is primarily related to the excessive release of thyroid hormones into the bloodstream.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A thyroid storm, also known as thyrotoxic crisis, is a rare but life-threatening medical emergency that occurs in individuals with severe hyperthyroidism. Hyperthyroidism is a condition in which the thyroid gland produces an excessive amount of thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3). In a thyroid storm, these hormone levels become dangerously elevated, leading to a wide range of symptoms and complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Symptoms of a thyroid storm may include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">High fever</span></li><li><span style=\"font-size:12.0pt;\">Rapid and irregular heartbeat (tachycardia)</span></li><li><span style=\"font-size:12.0pt;\">Elevated blood pressure</span></li><li><span style=\"font-size:12.0pt;\">Extreme agitation and restlessness</span></li><li><span style=\"font-size:12.0pt;\">Profuse sweating</span></li><li><span style=\"font-size:12.0pt;\">Tremors and shaking</span></li><li><span style=\"font-size:12.0pt;\">Nausea, vomiting, and diarrhea</span></li><li><span style=\"font-size:12.0pt;\">Delirium or confusion</span></li><li><span style=\"font-size:12.0pt;\">Jaundice (yellowing of the skin and eyes)</span></li><li><span style=\"font-size:12.0pt;\">Coma (in severe cases)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thyroid storms can be triggered by various factors, such as surgery, infection, trauma, or medication changes in individuals with underlying hyperthyroidism. The condition is more common in people with Graves' disease, a common cause of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment of a thyroid storm is a medical emergency and typically involves a combination of interventions to rapidly lower thyroid hormone levels, control symptoms, and support vital organ function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The usual cause of thyroid storm in thyroidectomy is inadequate patient preparation before surgery. Thus, patient preparation pre-operatively involves ensuring a euthyroid state.</span></p>",
    "correct_choice_id": 57599,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63683,
    "choices": [
      {
        "id": 253937,
        "text": "<p><span style=\"font-size:12.0pt;\">Both assertion and reason are true and the reason is the correct explanation of the assertion.</span></p>"
      },
      {
        "id": 253938,
        "text": "<p><span style=\"font-size:12.0pt;\">Both the assertion and reason are true statements, but the reason is not the correct explanation of the assertion.</span></p>"
      },
      {
        "id": 253939,
        "text": "<p><span style=\"font-size:12.0pt;\">Assertion is true but the reason is false.</span></p>"
      },
      {
        "id": 253940,
        "text": "<p><span style=\"font-size:12.0pt;\">Assertion is false but the reason is true.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\"><strong>Assertion</strong>: Ultrasonography is the primary imaging modality for the screening and diagnosis of IVH and parenchymal hemorrhage in neonates.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Reason</strong>: The posterior fontanelle offers a good acoustic window for imaging using USG.</span></p>",
    "unique_key": "Q8827220",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822661,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Assertion is true but the reason is false.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Ultrasonography (USG) is indeed the primary imaging modality for screening and diagnosing intraventricular hemorrhage (IVH) and parenchymal hemorrhage in neonates. This is because USG is non-invasive, quick, safe, and can be easily performed at the bedside, which is ideal for neonates in a critical care setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The assertion is correct, but the reason given is incorrect. The appropriate acoustic window for imaging IVH and other intracranial structures in neonates is the anterior fontanelle, not the posterior fontanelle. The anterior fontanelle provides a larger and more accessible window, which is optimal for visualizing the brain structures in detail.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Neonates at high risk for IVH, such as those with a gestational age below 32 weeks or a birth weight under 1500 grams, should undergo routine screening. Additionally, more mature preterm infants (32-34 weeks) should also be considered for screening if they experience complications postnatally, such as shock, unexplained anemia, or severe respiratory distress requiring mechanical ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The anterior fontanelle, not the posterior, is the primary acoustic window used in ultrasonography for imaging intracranial structures in neonates.</span></p>",
    "correct_choice_id": 253939,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 60737,
    "choices": [
      {
        "id": 242241,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Somatic hypermutation</span></span></span></p>"
      },
      {
        "id": 242242,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alternative RNA splicing</span></span></span></p>"
      },
      {
        "id": 242243,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Affinity maturation</span></span></span></p>"
      },
      {
        "id": 242244,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Allelic exclusion</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B cells express IgM and IgD antibodies at the same time due to which phenomenon?</span><span style=\"background-color:lime\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>",
    "unique_key": "Q3553261",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822818,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Alternative RNA splicing</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">B cells are capable of expressing IgM and IgD antibodies simultaneously through a process known as alternative RNA splicing. This process allows different proteins to be synthesized from the same RNA transcript by splicing the RNA in various ways. During the maturation of B cells, both IgM and IgD are expressed on their surfaces before further differentiation into specific antibodies. The heavy chains for these antibodies, &mu; (mu) for IgM and &delta; (delta) for IgD, are encoded in the same primary RNA transcript and are processed through alternative RNA splicing, allowing the production of both antibodies on the B cell surface.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Somatic hypermutation</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Somatic hypermutation is a mechanism that modifies the variable region of immunoglobulin genes in B cells to increase their affinity for antigens. This is part of the process by which B cells undergo affinity maturation, allowing them to produce high-affinity antibodies after exposure to antigens. It does not explain the simultaneous expression of IgM and IgD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Affinity maturation</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Affinity maturation is the process by which B cells produce antibodies with increased binding affinity for specific antigens. This occurs as a result of somatic hypermutation and subsequent selection of B cells with higher affinity receptors. Affinity maturation does not play a role in the expression of IgM and IgD simultaneously.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Allelic exclusion</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Allelic exclusion ensures that each B cell produces an antibody with a single specificity. It allows the expression of only one allele of the immunoglobulin heavy chain and one allele of the light chain, thus ensuring monospecificity. This process does not account for the simultaneous presence of IgM and IgD on B cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">B cells express both IgM and IgD simultaneously on their surfaces through the process of alternative RNA splicing. This mechanism allows different proteins to be produced from the same RNA transcript by selectively splicing it into different forms, enabling the expression of both isotypes.</span></span></span></p>",
    "correct_choice_id": 242242,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6709,
    "choices": [
      {
        "id": 26805,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
      },
      {
        "id": 26806,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 26807,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 26808,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A persistent alcoholic patient presents with convulsions and impaired sensorium. He has been drinking for ten years and consumes 24 units every day. His most recent drink was two days ago. He is discovered to have auditory hallucinations as well as secondary delusions. What method will you employ to manage this patient?</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Diazepam</span></li><li><span style=\"font-size:12.0pt;\">Thiamine</span></li><li><span style=\"font-size:12.0pt;\">Naltrexone</span></li><li><span style=\"font-size:12.0pt;\">Flupenthixol depot injection</span></li></ol>",
    "unique_key": "Q5993859",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822826,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is presenting with symptoms of alcohol withdrawal, specifically delirium tremens, characterized by tremors, altered sensorium, hallucinations, seizures, and agitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Diazepam:</strong> Benzodiazepines, like diazepam, are the first line of treatment for alcohol withdrawal symptoms and can help reduce the severity of symptoms, prevent seizures, and can be titrated based on the severity of withdrawal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Thiamine</strong>: Chronic alcoholics are at risk for thiamine (Vitamin B1) deficiency, leading to Wernicke's encephalopathy. It is important to administer thiamine before or with the first dose of glucose-containing fluids or foods to prevent precipitating or exacerbating Wernicke's encephalopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Naltrexone:</strong> This is an opioid antagonist that is used to decrease alcohol cravings. It is not directly useful in treating acute withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Flupenthixol depot injection:</strong> This is an antipsychotic medication. It is not the primary treatment for alcohol withdrawal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12.0pt;\">Alcohol withdrawal delirium (DTs) typically presents 48-72 hours after the last drink and is characterized by disturbances of consciousness, disorientation to time, place, and person, hallucinations (especially visual), agitation, coarse tremors and autonomic hyperactivity. Risk factors include surgery, infections or other medical conditions. It is a medical emergency requiring prompt intervention. Treatment includes intravenous lorazepam or diazepam with thiamine supplementation to prevent Wernicke encephalopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 472-473.</strong></span></p>",
    "correct_choice_id": 26808,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63673,
    "choices": [
      {
        "id": 253897,
        "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-a, 4-d</span></p>"
      },
      {
        "id": 253898,
        "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-d, 4-a</span></p>"
      },
      {
        "id": 253899,
        "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-d, 3-c, 4-b</span></p>"
      },
      {
        "id": 253900,
        "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Match the items in Column A with their correct description in Column B:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Column A:</strong></span></p><p><span style=\"font-size:16px;\">1. Primary survey</span></p><p><span style=\"font-size:16px;\">2. Secondary survey</span></p><p><span style=\"font-size:16px;\">3. Definitive care</span></p><p><span style=\"font-size:16px;\">4. Resuscitation</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Column B:</strong></span><br><span style=\"font-size:16px;\">a. Make a management plan</span><br><span style=\"font-size:16px;\">b. Identify what can cause death</span><br><span style=\"font-size:16px;\">c. Identify other injuries</span><br><span style=\"font-size:16px;\">d. Treat what can cause death</span></p>",
    "unique_key": "Q4741347",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822845,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) &nbsp;1-b, 2-c, 3-a, 4-d</strong></span></p><p><br><span style=\"font-size:16px;\">The steps outlined are part of the Advanced Trauma Life Support (ATLS) protocol, designed to assess and manage trauma patients systematically.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Primary Survey</strong> involves the ABCDE approach (Airway, Breathing, Circulation, Disability, Exposure), focusing on identifying and treating immediate life-threatening issues. It emphasizes identifying what can cause death.</span></li><li><span style=\"font-size:16px;\"><strong>Secondary Survey</strong> is a thorough head-to-toe evaluation after initial stabilization. This step is intended to identify other injuries that may not be immediately life-threatening.</span></li><li><span style=\"font-size:16px;\"><strong>Definitive Care</strong> involves creating a comprehensive treatment plan based on findings from the primary and secondary surveys, hence making a management plan.</span></li><li><span style=\"font-size:16px;\"><strong>Resuscitation</strong> is simultaneous with the primary survey to stabilize vital signs and provide essential interventions, focusing on treating what can cause death immediately, such as hemorrhage control and airway support.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">ATLS protocol steps emphasize a structured approach for trauma assessment, prioritizing immediate life-threatening conditions first, followed by a comprehensive examination and a definitive management plan.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Primary survey -<strong> Identify what can cause death</strong></span></li><li><span style=\"font-size:16px;\">Secondary survey -<strong> Identify other injuries</strong></span></li><li><span style=\"font-size:16px;\">Definitive care - <strong>Make a management plan</strong></span></li><li><span style=\"font-size:16px;\">Resuscitation - <strong>Treat what can cause death</strong></span></li></ol>",
    "correct_choice_id": 253897,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10100,
    "choices": [
      {
        "id": 40366,
        "text": "<p><span style=\"font-size:12.0pt;\">Antibodies against desmoglein 3</span></p>"
      },
      {
        "id": 40367,
        "text": "<p><span style=\"font-size:12.0pt;\">Antibodies against desmoglein 1</span></p>"
      },
      {
        "id": 40368,
        "text": "<p><span style=\"font-size:12.0pt;\">Suprabasal acantholytic blister is a characteristic feature</span></p>"
      },
      {
        "id": 40369,
        "text": "<p><span style=\"font-size:12.0pt;\">Antibodies against hemidesmosomes</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman presented with painful blisters on the skin and oral mucosa. Direct immunofluorescence is given below. Which of the following is false regarding the same?</span> (AIIMS MAY 2017)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/30.jpg\" alt=\"\" width=\"422\" height=\"392\"></span></p>",
    "unique_key": "Q8649181",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822660,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Antibiotics against hemidesmosomes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows a characteristic fish-net appearance on direct immunofluorescence, which is diagnostic of pemphigus vulgaris.</span></p><p>&nbsp;</p><p>The question talking about the false statement.</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In direct immunofluorescence testing for pemphigus vulgaris, the immunoglobulin deposition is observed along the plasma membranes of epidermal keratinocytes in a <strong>reticular or fishnet-like pattern</strong>, indicating an autoantibody attack against desmosomal adhesion proteins. This results in early <strong>suprabasal separation</strong> and loss of cell-to-cell adhesion (acantholysis). The severity and position of the blisters are related to the distribution <strong>of desmoglein 1 and 3 in the epidermis</strong> and the presence of autoantibodies to one or both proteins. The antibodies primarily disrupt the intercellular adhesive function of the desmosomes and may activate intercellular proteases. The observed pattern is due to the interepidermal <strong>intercellular deposition of IgG and C3</strong>. The <strong>Tzanck smear is the preferred initial test</strong>, which involves collecting material from the floor of a fresh blister for microscopic examination, <strong>using Giemsa or Romanowsky stain</strong>. The presence of <strong>Tzank cells confirms the diagnosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is incorrect and hence the false statement. Hemidesmosomes are associated with a different condition called <strong>bullous pemphigoid</strong>, where autoantibodies target components of the basement membrane, not the desmosomes as in pemphigus vulgaris.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Antibodies against desmoglein 3</strong>: This statement is true, as pemphigus vulgaris involves antibodies against desmoglein 3, particularly in mucosal lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Antibodies against desmoglein 1</strong>: This statement is also true. Pemphigus vulgaris can involve antibodies against desmoglein 1, which is primarily found in the superficial layers of the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Suprabasal acantholytic blister is a characteristic feature</strong>: This is correct, as pemphigus vulgaris is characterized by suprabasal blisters formed due to acantholysis, resulting from the disruption of desmosomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris is characterized by autoantibodies against desmosomal proteins (desmoglein 1 and 3), leading to a suprabasal acantholytic blister and a diagnostic fish-net appearance on direct immunofluorescence.</span></p>",
    "correct_choice_id": 40369,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 31805,
    "choices": [
      {
        "id": 127090,
        "text": "<p><span style=\"font-size:12pt;\">Tacrolimus</span></p>"
      },
      {
        "id": 127091,
        "text": "<p><span style=\"font-size:12pt;\">Nifedipine</span></p>"
      },
      {
        "id": 127092,
        "text": "<p><span style=\"font-size:12pt;\">Diltiazem</span></p>"
      },
      {
        "id": 127093,
        "text": "<p><span style=\"font-size:12pt;\">Verapamil</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following drugs is an inhibitor of ATP binding cassette efflux pumps? (INICET NOV 2023)</span></p>",
    "unique_key": "Q6250504",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822840,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Verapamil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Verapamil is known to inhibit the activity of ATP-binding cassette (ABC) transporters, such as P-glycoprotein, which is one of the most well-studied drug efflux transporters. By inhibiting P-glycoprotein, verapamil can increase the intracellular concentration of various drugs, which is why it is sometimes used as a pharmacokinetic enhancer to improve drug absorption and decrease drug clearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Tacrolimus:</strong> Tacrolimus is an immunosuppressant drug used mainly after allogeneic organ transplant to reduce the activity of the patient's immune system and lower the risk of organ rejection. It is not an inhibitor of the ATP-binding cassette efflux transporters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Nifedipine:</strong> Nifedipine is a calcium channel blocker used primarily to treat hypertension and angina pectoris. It is not known to inhibit ABC efflux transporters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Diltiazem:</strong> Diltiazem, like verapamil, is a calcium channel blocker, but it is not as potent as verapamil in inhibiting P-glycoprotein. However, it does have some effect on drug efflux transporters, but to a lesser extent compared to verapamil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Verapamil is a known inhibitor of ATP-binding cassette transporters, particularly P-glycoprotein, and can be used to enhance the pharmacokinetics of various drugs by increasing their intracellular concentrations.</span></p>",
    "correct_choice_id": 127093,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6840,
    "choices": [
      {
        "id": 27328,
        "text": "<p><span style=\"font-size:12.0pt;\">Cadherin</span></p>"
      },
      {
        "id": 27329,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitronectin</span></p>"
      },
      {
        "id": 27330,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibronectin</span></p>"
      },
      {
        "id": 27331,
        "text": "<p><span style=\"font-size:12.0pt;\">Selectin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#040c28;font-size:12.0pt;\">Which of the following is high-molecular weight glycoprotein of the extracellular matrix that binds to integrins? (</span>AIIMS May 2018)</p>",
    "unique_key": "Q1135818",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822825,
    "difficulty_level": "difficult",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Fibronectin</strong></span></p><p>&nbsp;</p><p><span style=\"color:#040c28;font-size:12.0pt;\">Fibronectin is a high-molecular weight (~500-~600 kDa) glycoprotein of the extracellular matrix that binds to membrane-spanning receptor proteins called integrins</span><span style=\"background-color:white;color:#4d5156;font-size:12.0pt;\">.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Integrins are cell surface receptors that play a crucial role in connecting cells to their extracellular environment, including other cells and the extracellular matrix (ECM). Integrins can connect with several types of molecules and proteins, including:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Extracellular Matrix (ECM) Proteins:&nbsp;</strong>Integrins can bind to various components of the ECM, such as fibronectin, laminin, collagen, and vitronectin. These interactions allow cells to anchor to the ECM and provide structural support.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cell Adhesion Molecules:&nbsp;</strong>Integrins can connect with other cell adhesion molecules on neighbouring cells, promoting cell-cell interactions and the formation of multicellular structures. Examples of cell adhesion molecules include cadherins, selectins, and immunoglobulin superfamily proteins.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Signalling Proteins:&nbsp;</strong>Integrins can also associate with intracellular signalling proteins, such as focal adhesion kinases (FAK), Src family kinases, and various adapter proteins. These interactions transmit signals from the ECM to the cell's interior, influencing cellular processes like cell growth, migration, and differentiation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Blood Clotting Factors:&nbsp;</strong>In platelets, integrins can bind to fibrinogen and von Willebrand factor, contributing to platelet aggregation and blood clot formation.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cadherin:&nbsp;</strong>Involved in calcium-dependent cell-cell adhesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vitronectin:&nbsp;</strong>Also a part of the extracellular matrix but known for its role in serum spreading factor and in the promotion of cell adhesion and spreading.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Selectin:&nbsp;</strong>Plays a role in cell adhesion during the immune response, particularly in the binding of white blood cells to the endothelium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fibronectin is a key component of the extracellular matrix that interacts with cell surface integrins to mediate various cellular processes including adhesion, migration, and tissue repair.</span></p>",
    "correct_choice_id": 27330,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54269,
    "choices": [
      {
        "id": 216545,
        "text": "<p><span style=\"font-size:12.0pt;\">S. glucose &gt; 250 mg/dL</span></p>"
      },
      {
        "id": 216546,
        "text": "<p><span style=\"font-size:12.0pt;\">Arterial pH &lt; 7.3</span></p>"
      },
      {
        "id": 216547,
        "text": "<p><span style=\"font-size:12.0pt;\">Anion gap &gt; 12</span></p>"
      },
      {
        "id": 216548,
        "text": "<p><span style=\"font-size:12.0pt;\">S. Potassium &lt; 3.5 mEq/L</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All of the following are criteria for diagnosis of DKA except:</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q5186614",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822677,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>&nbsp;Ans. D) S. Potassium &lt; 3.5 mEq/L</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diabetic ketoacidosis (DKA) is a serious complication of diabetes characterized by hyperglycemia, ketosis, and metabolic acidosis. The diagnostic criteria for DKA typically include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hyperglycemia:</strong> Blood glucose levels greater than 250 mg/dL.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ketosis:</strong> Presence of ketones in the blood or urine.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Metabolic Acidosis:</strong> Indicated by an arterial pH of less than 7.3, a serum bicarbonate level of less than 15-18 mEq/L, and an anion gap greater than 12.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>S. Potassium &lt; 3.5 mEq/L</strong> is not a diagnostic criterion for DKA. Although potassium imbalance is common in DKA due to shifts between the intracellular and extracellular compartments, serum potassium levels are not used as a diagnostic criterion. Potassium levels can vary and might be normal, elevated, or decreased, depending on the stage of DKA and the treatment administered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. S. glucose &gt; 250 mg/dL:</strong> This is a diagnostic criterion for DKA as it confirms the presence of significant hyperglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Arterial pH &lt; 7.3:</strong> This indicates metabolic acidosis, which is a key component of DKA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anion gap &gt; 12:</strong> An increased anion gap signifies high anion gap metabolic acidosis (HAGMA), which is typical in DKA due to the presence of ketone bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnostic criteria for DKA include hyperglycemia, ketosis, and metabolic acidosis with an increased anion gap. Potassium levels, while important to monitor and manage in DKA, are not part of the diagnostic criteria.</span></p>",
    "correct_choice_id": 216548,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 2161,
    "choices": [
      {
        "id": 8633,
        "text": "<p><span style=\"font-size:12.0pt;\">Interferes with alcohol metabolism</span></p>"
      },
      {
        "id": 8634,
        "text": "<p><span style=\"font-size:12.0pt;\">Interferes with transketolase activity</span></p>"
      },
      {
        "id": 8635,
        "text": "<p><span style=\"font-size:12.0pt;\">Is coenzyme for pyruvate and alpha ketoglutarate dehydrogenase</span></p>"
      },
      {
        "id": 8636,
        "text": "<p><span style=\"font-size:12.0pt;\">Interferes with energy production from amino acids</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Thiamine deficiency results in decreased energy production, because TPP? (</span>AIIMS Nov 2017)</p>",
    "unique_key": "Q2559396",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822854,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Is coenzyme for pyruvate and alpha ketoglutarate dehydrogenase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyruvate and \u03b1-ketoglutarate dehydrogenase <strong>use Thiamine as a co-enzyme to produce ATP</strong> using NADH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Thiamine also acts as a coenzyme for transketolase in the pentose phosphate pathway (HMP shunt</strong>) but there is no ATP generation here, hence option C is correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Physiological Role of Thiamine:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Pyruvate dehydrogenase:&nbsp;</strong>The co-enzyme form is <strong>thiamine pyrophosphate (TPP)</strong>. It is used in oxidative decarboxylation of alpha keto acids, e.g. pyruvate dehydrogenase catalyzes the breakdown of pyruvate, to acetyl CoA, and carbon dioxide</span></li><li><span style=\"font-size:12.0pt;\"><strong>Alpha ketoglutarate dehydrogenase</strong>: An analogous biochemical reaction that requires TPP is the <strong>oxidative decarboxylation of alpha ketoglutarate to succinyl CoA and CO<sub>2</sub></strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Transketolase:&nbsp;</strong>The second group of enzymes that use TPP as co-enzyme are the transketolases, in the <strong>hexose monophosphate shunt pathway</strong> of glucose.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>The main role of thiamine (TPP) is in carbohydrate metabolism.&nbsp;</strong>So, the requirement of thiamine is increased along with higher intake of carbohydrates</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Interferes with alcohol metabolism</strong>: While thiamine is important for alcohol metabolism, the primary reason for decreased energy production in thiamine deficiency is its role in the citric acid cycle, not alcohol metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Interferes with transketolase activity</strong>: Although TPP is a coenzyme for transketolase, this enzyme operates in the pentose phosphate pathway, which does not generate ATP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Interferes with energy production from amino acids</strong>: Thiamine's primary role is in carbohydrate metabolism through its function in the citric acid cycle, not directly in amino acid metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thiamine deficiency leads to decreased energy production because thiamine pyrophosphate (TPP) is a critical coenzyme for pyruvate and alpha-ketoglutarate dehydrogenase in the citric acid cycle, essential for ATP generation.</span></p>",
    "correct_choice_id": 8635,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14862,
    "choices": [
      {
        "id": 59408,
        "text": "<p><span style=\"font-size:12.0pt;\">Chondrosarcoma</span></p>"
      },
      {
        "id": 59409,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteosarcoma</span></p>"
      },
      {
        "id": 59410,
        "text": "<p><span style=\"font-size:12.0pt;\">GCT</span></p>"
      },
      {
        "id": 59411,
        "text": "<p><span style=\"font-size:12.0pt;\">Chondroblastoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 10-year-old child was operated for a tumour in the lower end of femur. The gross specimen of the resected tumour is shown below. What is the diagnosis? (INCET MAY 2020)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/08/io40.jpg\" alt=\"\" width=\"442\" height=\"185\"></p>",
    "unique_key": "Q2935791",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822858,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B)</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Osteosarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>OSTEOSARCOMA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The matrix forming the tumor is the cause of calcification.</span></li><li><span style=\"font-size:12.0pt;\">It is the second most common primary malignancy of bone behind multiple myeloma.</span></li><li><span style=\"font-size:12.0pt;\">The classic form of osteosarcoma is typically seen in patients in their second or third decade, with a peak in the adolescent growth spurt.</span></li><li><span style=\"font-size:12.0pt;\">It occurs more frequently in males than in females and is found in the metaphyseal areas of long bones, with 50% of lesions about the knee joint.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>distal femur is the most common site</strong>, followed by the proximal tibia and then the proximal humerus.</span></li><li><span style=\"font-size:12.0pt;\">Characteristic histological feature is malignant cells with osteoid formation. This osteoid matrix presents as calcification.</span></li><li><span style=\"font-size:12.0pt;\">Osteosarcoma is the most common radiation-induced sarcoma.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Almost all patients report progressive <strong>pain</strong>. Night pain may be an important clue to the true diagnosis, seen in 25% of patients</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Radiological Features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Permeated lytic destruction of metaphyseal bone, with eventual cortical breakthrough into the subperiosteal space and subsequent formation of a <strong>Codman triangle at the diaphyseal end of the tumor</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/06/picture1_Gl2GIva.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Codman\u2019s triangle</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">As the tumor continues to push its way into the extracortical soft tissue, a typical <strong>sunburst pattern of neoplastic bone</strong> may be seen outside the involved bone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/06/picture2_OlAQ2Xq.jpg\" alt=\"\" width=\"500\" height=\"311\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">MRI is the best test to measure the extent of the tumor within the bone and in the soft tissue and to determine the relationship of the tumor to nearby anatomical structures.</span></li><li><span style=\"font-size:12.0pt;\">A bone scan should be obtained to look for skeletal metastases, and radiographs and CT scans of the chest should be done to search for pulmonary metastases; the lungs are the most common sites of metastases.</span></li><li><span style=\"font-size:12.0pt;\">CT scan may be helpful in differentiating osteosarcoma from myositis ossificans or an osteochondroma. The ossification in myositis ossificans is more mature at the periphery of the lesion, whereas the center of osteosarcoma is more heavily ossified.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\">It is highly radio-resistant tumor and ideally, treated by chemotherapy followed by limb salvage surgery/amputation followed by chemotherapy.</span></li><li><span style=\"font-size:12.0pt;\">With the combination of chemotherapy and surgical treatment, the prognosis for 5-year survival is 70-80%.</span></li><li><span style=\"font-size:12.0pt;\">The drugs commonly used today include high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide.</span></li><li><span style=\"font-size:12.0pt;\">In osteosarcoma of the extremities, limb-sparing surgery with wide resection of the tumor is the standard approach.</span></li><li><span style=\"font-size:12.0pt;\">Amputation is reserved for the exceptional or recurrent case.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chondrosarcoma.&nbsp;</strong>It occurs over a broad age range, with peaks between 40 and 60 years for primary chondrosarcoma and between 25 and 45 years for secondary chondrosarcoma. Most common in Proximal location like <strong>pelvis (most common site)</strong>, proximal femur, and proximal humerus. Most common malignant tumor of bone in hand (although rarely occur). Secondary chondrosarcomas arise at the site of a pre-existing benign cartilage lesion like in case of <strong>multiple enchondromas and multiple hereditary exostoses. </strong>Chondrosarcoma <strong>can produce hyperglycemia</strong> in 85% cases. Metastasis from Chondrosarcoma most commonly goes to lungs (hematogenous). The radiographic appearance is similar to enchondroma, it is a lesion arising in the medullary cavity with irregular matrix calcification. The pattern of Calcification is described as <strong>\u201cPunctate\u201d, \u201cpopcorn\u201d, or \u201ccomma-shaped\u201d</strong>. It has a more aggressive appearance with Bone destruction, cortical erosions, periosteal reaction, and rarely a soft-tissue mass. Treatment is by<strong> </strong>Wide local excision/Radical excision.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/06/picture36.jpg\" alt=\"\" width=\"500\" height=\"293\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. GCT.&nbsp;</strong>They typically occur in patients <strong>20-40 years old</strong>, and there is a slight <strong>female predominance</strong>. The most common location for this tumor is the distal femur, followed closely by the proximal tibia. <strong>Tumor of lower end radius is GCT till proved otherwise. </strong>GCT has egg shell crackling on palpation. Although these tumors typically are benign, pulmonary metastases occur in approximately 3% of patients. Malignant giant cell tumors represent less than 5% of total GCT. Radiographic findings often are diagnostic. The lesions are eccentrically located in the epiphyses of long bones and usually about the subchondral bone with <strong>soap bubble appearance</strong>. Microscopically, giant cell tumors are composed of many multinucleated giant cells (typically 40-60 nuclei per cell) in a sea of mononuclear stromal cells (malignant cells). Curettage and stripping of the cavity is the treatment of choice.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/06/picture4_LMkxVjy.jpg\" alt=\"\" width=\"500\" height=\"240\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chondroblastoma.&nbsp;</strong>Chondroblastoma is a rare type of benign tumor that grows at the ends of the long bones, close to the joints. Most often, the tumors develop at the ends of the femur, tibia, or humerus. They typically occur in children and young adults, and are more common in males. Although chondroblastomas are not cancerous, they can continue to grow if left untreated. A growing tumor can destroy the surrounding bone, making it painful to move the nearby joint. The cause of chondroblastomas is not known. The tumors are thought to arise from the growth plates at the ends of the bones, near joints. Classic <strong>\u201cchicken wire\u201d </strong>calcification is seen. Epiphysis + calcification + upper end humerus = Chondroblastoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/06/picture5_ByldorW.jpg\" alt=\"\" width=\"250\" height=\"395\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given image in the question shows a cut section of osteosarcoma of the femur.</span></li><li><span style=\"font-size:12.0pt;\">The destructive tumor arises from the metaphysis, with extensive involvement of the marrow cavity and extension into soft tissue.</span></li></ul>",
    "correct_choice_id": 59409,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63685,
    "choices": [
      {
        "id": 253945,
        "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reason are correct statements and the Reason is the correct explanation for the Assertion.</span></p>"
      },
      {
        "id": 253946,
        "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reason are correct statements, but the Reason is not the correct explanation for the Assertion.</span></p>"
      },
      {
        "id": 253947,
        "text": "<p><span style=\"font-size:12.0pt;\">The assertion is correct statement, but the Reason is an incorrect statement.</span></p>"
      },
      {
        "id": 253948,
        "text": "<p><span style=\"font-size:12.0pt;\">The assertion is a incorrect statement, but the Reason is a correct statement.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\"><strong>Assertion</strong>: A patient comatose due to stroke in the past few hours should be intubated.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Reason</strong>: Following a stroke, there are high chances of a patient having sleep apnea.&nbsp;</span></p>",
    "unique_key": "Q7436972",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822666,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) The assertion is correct statement, but the Reason is an incorrect statement.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A patient who is comatose due to a recent stroke should indeed be intubated due to the increased risk of aspiration pneumonia. Stroke can impair swallowing reflexes and gag reflexes, which heightens the risk of aspiration and subsequent respiratory complications. This need for intubation is directly related to the prevention of aspiration, not to sleep apnea.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The Reason provided in the statement is incorrect because, although sleep apnea can occur in some stroke patients, it is not a common acute complication requiring immediate intervention. The primary concern in an unconscious stroke patient is the risk of aspiration, not sleep apnea. Thus, the assertion is true, but the reason is false.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In cases of comatose stroke patients, intubation is indicated primarily to prevent aspiration pneumonia due to compromised protective reflexes, not due to concerns about sleep apnea.</span></p>",
    "correct_choice_id": 253947,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 1970,
    "choices": [
      {
        "id": 7873,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Human cells can divide a finite number of times only</span></p>"
      },
      {
        "id": 7874,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Free radical oxidation level is unrestricted</span></p>"
      },
      {
        "id": 7875,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Telomerase activity is unrestricted</span></p>"
      },
      {
        "id": 7876,
        "text": "<p><span style=\"font-size:12.0pt;\">RNA polymerase can function for a finite number of times only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is true about the Hayflick limit? (</span>INICET May 2020)</p>",
    "unique_key": "Q6839239",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822830,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Human cells can divide a finite number of times only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Leonard Hayflick discovered that cultured normal human cells have limited capacity to divide, after which they become senescent \u2014 a phenomenon now known as the \u2018Hayflick limit\u2019</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Each time a cell undergoes mitosis, the telomeres on the ends of each chromosome shorten slightly. Cell division will cease once telomeres shorten to a critical length. Hayflick interpreted his discovery to be aging at the cellular level. The aging of cell populations appears to correlate with the overall physical aging of an organism. <strong>Normal human fetal cell population will divide between 40 and 60 times in cell culture before entering a senescence phase. However, this limit does not apply to stem cells.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Free radical oxidation level is unrestricted: </strong>Free radical oxidation is related to oxidative stress and damage but is not directly related to the Hayflick limit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Telomerase activity is unrestricted: </strong>In most somatic cells, telomerase activity is limited, leading to telomere shortening. However, certain cells like stem cells and cancer cells exhibit higher telomerase activity, allowing them to bypass the Hayflick limit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. RNA polymerase can function for a finite number of times only: </strong>RNA polymerase activity is not directly linked to the Hayflick limit and does not have a finite number of times it can function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Hayflick limit describes the finite number of times that normal human cells can divide before they become senescent, primarily due to telomere shortening.</span></p>",
    "correct_choice_id": 7873,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74896,
    "choices": [
      {
        "id": 298481,
        "text": "<p><span style=\"font-size:16px;\">Microangiopathic hemolytic anemia</span></p>"
      },
      {
        "id": 298482,
        "text": "<p><span style=\"font-size:16px;\">Thrombocytopenia</span></p>"
      },
      {
        "id": 298483,
        "text": "<p><span style=\"font-size:16px;\">Renal failure</span></p>"
      },
      {
        "id": 298484,
        "text": "<p><span style=\"font-size:16px;\">Thrombosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not a component of Thrombotic Thrombocytopenic Purpura (TTP)? (INICET NOV 2024)</span></p>",
    "unique_key": "Q7329846",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822839,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Thrombosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">TTP is characterized by a pentad of clinical findings:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Fever</span></li><li><span style=\"font-size:16px;\">Microangiopathic hemolytic anemia with schistocytes/helmet cells</span></li><li><span style=\"font-size:16px;\">Thrombocytopenia</span></li><li><span style=\"font-size:16px;\">Renal failure</span></li><li><span style=\"font-size:16px;\">Neurological involvement</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">TTP is caused by ADAMTS13 deficiency, which leads to excessive formation of platelet microthrombi in small vessels. While microvascular thrombosis occurs, macrovascular thrombosis is not a defining feature of TTP.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The classic pentad of TTP consists of fever, microangiopathic hemolytic anemia, thrombocytopenia, renal failure, and neurological involvement. Macrovascular thrombosis is not a defining feature of TTP, unlike in conditions such as antiphospholipid syndrome, where both macro- and microvascular thrombosis can occur.</span></p>",
    "correct_choice_id": 298484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73701,
    "choices": [
      {
        "id": 293745,
        "text": "<p><span style=\"font-size:16px;\">1, 2 and 3</span></p>"
      },
      {
        "id": 293746,
        "text": "<p><span style=\"font-size:16px;\">1 and 3</span></p>"
      },
      {
        "id": 293747,
        "text": "<p><span style=\"font-size:16px;\">1, 2, 3 and 4</span></p>"
      },
      {
        "id": 293748,
        "text": "<p><span style=\"font-size:16px;\">3 and 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following statements regarding the causes of fall in diastolic blood pressure is correct? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Loss of sympathetic outflow in the lumbar region</span></li><li><span style=\"font-size:16px;\">Antagonism of beta-1 adrenergic receptors</span></li><li><span style=\"font-size:16px;\">Blockade of alpha-1 adrenergic receptors</span></li><li><span style=\"font-size:16px;\">Antagonism of beta-2 adrenergic receptors</span></li></ol>",
    "unique_key": "Q7624698",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822841,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) 1 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">A fall in diastolic blood pressure primarily occurs due to vasodilation. Two mechanisms listed that cause vasodilation are:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Loss of sympathetic outflow in lumbar region</strong>: Sympathetic system causes vasoconstriction, so its loss leads to vasodilation</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Blockade of alpha-1 adrenergic receptors</strong>: Alpha-1 receptors mediate vasoconstriction, so their blockade causes vasodilation</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:16px;\"><strong>2. Antagonism of beta-1 adrenergic receptors</strong>: Incorrect. Beta-1 blockade primarily affects heart rate and contractility, leading to decreased systolic blood pressure, not diastolic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. Antagonism of beta-2 adrenergic receptors</strong>: Incorrect. Beta-2 receptors mediate vasodilation, so their blockade would cause vasoconstriction and potentially increase diastolic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">Diastolic blood pressure is primarily affected by vascular tone - vasodilation decreases it (through loss of sympathetic tone or alpha-1 blockade) while vasoconstriction increases it.</span></p>",
    "correct_choice_id": 293746,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11833,
    "choices": [
      {
        "id": 47298,
        "text": "<p><span style=\"font-size:12.0pt;\">1-5% of the population can have epileptiform discharges.</span></p>"
      },
      {
        "id": 47299,
        "text": "<p><span style=\"font-size:12.0pt;\">Scalp EEG may be helpful in localizing frontal lobe epilepsy.</span></p>"
      },
      {
        "id": 47300,
        "text": "<p><span style=\"font-size:12.0pt;\">Doing EEG is mandatory for the diagnosis of seizures.</span></p>"
      },
      {
        "id": 47301,
        "text": "<p><span style=\"font-size:12.0pt;\">Progressive multifocal leukoencephalopathy shows triphasic and slow waves.</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">True about electroencephalogram (EEG) is all except: (INICET NOV 2021)</span></p>",
    "unique_key": "Q8403798",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822843,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Doing EEG is mandatory for the diagnosis of seizures.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Electroencephalography (EEG) is a key diagnostic tool in the evaluation of neurological conditions, particularly epilepsy. However, it is not mandatory for the diagnosis of seizures. A patient can have seizures even if their EEG results are normal. <strong>An abnormal EEG can provide reassurance of a diagnosis of epilepsy when the clinical context supports it, but a normal EEG does not rule out epilepsy or seizures.</strong> Therefore, making an EEG mandatory for the diagnosis of seizures is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>1-5% of the population can have epileptiform discharges: </strong>This statement is correct. Epileptiform discharges can be present in a small percentage of the general population without necessarily indicating that the individual has epilepsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Scalp EEG may be helpful in localizing frontal lobe epilepsy: </strong>This statement is correct. Scalp EEG can indeed help localize the origin of epileptic activity, including frontal lobe epilepsy, although it might not always be definitive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Progressive multifocal leukoencephalopathy shows triphasic and slow waves: </strong>This statement is correct. Progressive multifocal leukoencephalopathy (PML) and other forms of encephalopathy can show triphasic waves and slow wave patterns on an EEG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">EEG is not mandatory for the diagnosis of seizures as patients can have seizures even with a normal EEG.</span></p>",
    "correct_choice_id": 47300,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6731,
    "choices": [
      {
        "id": 26893,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in GFR</span></span></span></p>"
      },
      {
        "id": 26894,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases renal blood flow</span></span></p>"
      },
      {
        "id": 26895,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreases oncotic pressure in glomerular capillaries</span></span></span></p>"
      },
      {
        "id": 26896,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases hydrostatic pressure in glomerular capillaries</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efferent arteriolar constriction causes all except? (</span></span>AIIMS May 2017)</p>",
    "unique_key": "Q3144481",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822656,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Decreases oncotic pressure in glomerular capillaries</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-180328.png\" style=\"height:265px; width:400px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Efferent arteriolar constriction <strong>increases</strong> oncotic pressure in glomerular capillaries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Constriction of the efferent arterioles:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases the resistance to outflow from the glomerular capillaries raising the glomerular hydrostatic pressure</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces renal blood flow</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase in filtration fraction and glomerular colloid osmotic pressure (oncotic pressure) </span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, if the constriction of efferent arterioles is severe (more than about a threefold increase in efferent arteriolar resistance), the rise in colloid osmotic pressure (oncotic pressure) exceeds the increase in glomerular capillary hydrostatic pressure caused by efferent arteriolar constriction. When this occurs, the net force for filtration actually decreases, causing a reduction in GFR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Decrease in GFR:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect in this context as initial efferent arteriolar constriction might actually increase GFR by raising hydrostatic pressure, though severe constriction can eventually decrease it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Decreases renal blood flow:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as this is a direct effect of efferent arteriolar constriction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Increases hydrostatic pressure in glomerular capillaries:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as this is indeed a result of efferent arteriolar constriction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efferent arteriolar constriction leads to an increase in both hydrostatic and oncotic pressures within the glomerular capillaries, which can modify renal blood flow and the dynamics of glomerular filtration. It does not decrease the oncotic pressure in the glomerular capillaries.</span></span></p>",
    "correct_choice_id": 26895,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11156,
    "choices": [
      {
        "id": 44590,
        "text": "<p><span style=\"font-size:18px;\">2 drug therapy for 6 months</span></p>"
      },
      {
        "id": 44591,
        "text": "<p><span style=\"font-size:18px;\">3 drug therapy for 12 months</span></p>"
      },
      {
        "id": 44592,
        "text": "<p><span style=\"font-size:18px;\">2 drug therapy for 12 months</span></p>"
      },
      {
        "id": 44593,
        "text": "<p><span style=\"font-size:18px;\">3 drug therapy for 6 months</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 24-year-old man presents with 2-3 hypopigmented, slightly raised patches on his forearm with reduced sensation for 4 months. He is diagnosed with paucibacillary leprosy. What is the recommended treatment regimen? </strong><i><strong>[AIIMS NOV 2019]</strong></i></span></p>",
    "unique_key": "Q8805319",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822664,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) 2 drug therapy for 6 months</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The treatment regimen for paucibacillary leprosy involves a 6-month course of drug therapy with 2 drugs (Dapsone, Rifampicin).</span></li><li><span style=\"font-size:18px;\">Diagnosis of leprosy under NLEP: It is currently based on clinical grounds (revised case definition) -&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Paucibacillary (PB) case</strong>: A case of leprosy with 1 to 5 skin lesions, without demonstrated presence of bacilli in a skin smear;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Multibacillary (MB) case</strong>: A case of leprosy with more than five skin lesions; or with&nbsp;nerve involvement (pure neuritis, or any number of skin lesions and neuritis); or with the demonstrated presence of bacilli in a slit-skin smear, irrespective of the number of skin lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174718.jpg\" alt=\"\" width=\"800\" height=\"251\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/33333.jpg\" alt=\"\" width=\"250\" height=\"250\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>MDT blister pack Colour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">PBL adult - Green color</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">MBL adult - Red color</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">PBL child - Blue color</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">MBL child - Yellow colour&nbsp;</span></p>",
    "correct_choice_id": 44590,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54315,
    "choices": [
      {
        "id": 216729,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-1, C-4, D-2</span></span></p>"
      },
      {
        "id": 216730,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-1, D-4</span></span></p>"
      },
      {
        "id": 216731,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-4, C-2, D-1</span></span></p>"
      },
      {
        "id": 216732,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-1, C-2, D-1</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Match the blood product with the shelf life mentioned in the next column:</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-134922.jpg\" style=\"height:380px; width:700px\" /></span></span></span></p>",
    "unique_key": "Q3063389",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822675,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) A-3, B-1, C-4, D-2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The shelf lives of various blood products are crucial for ensuring their efficacy and safety in clinical use. Here is the matching of blood products with their respective shelf lives:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single donor platelet (A)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These typically have a shelf life of <strong>5 days (3.)</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Packed red blood cells (B)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These can be stored for up to <strong>42 days</strong> depending on the preservative used (1.).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryoprecipitate (C)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This blood product has a shelf life of <strong>1 year</strong> when stored properly (4.).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Granulocyte concentrate (D)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This product has a short shelf life of <strong>24 hours (2.)</strong>.<strong> </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">T</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">he shelf life of different blood products is essential for proper storage and timely usage in medical practice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single donor platelet - 5 days</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Packed red blood cells - 42 days</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryoprecipitate - 1 year</span></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granulocyte concentrate - 24 hours</span></span></li>\r\n</ul>",
    "correct_choice_id": 216729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6838,
    "choices": [
      {
        "id": 27320,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary active transport</span></span></span></p>"
      },
      {
        "id": 27321,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary active transport</span></span></span></p>"
      },
      {
        "id": 27322,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Facilitated diffusion</span></span></span></p>"
      },
      {
        "id": 27323,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Any of the above</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The mechanism by which glucose is absorbed in the intestine is? (</span></span>AIIMS May 2018)</p>",
    "unique_key": "Q1179921",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822856,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Secondary active transport</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose enters the lumen of the small intestine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium ions (Na+) are present in the lumen of the intestine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium-Glucose Co-Transporter 1 (SGLT1) on the luminal membrane of enterocytes facilitates glucose absorption:</span></span></span>\r\n\t<ol style=\"list-style-type:lower-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SGLT1 binds to both glucose and sodium ions.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium ions move down their electrochemical gradient into the enterocyte, providing energy for transport.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose molecules are co-transported with sodium ions into the enterocyte.</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose enters the cytoplasm of the enterocyte.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inside the enterocyte, glucose can be used for energy or transported across the basolateral membrane.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose Transporter 2 (GLUT2) on the basolateral membrane of enterocytes facilitates glucose transport out of the cell:</span></span></span>\r\n\t<ol style=\"list-style-type:lower-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">GLUT2 allows glucose to move down its concentration gradient.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose diffuses across the basolateral membrane into the bloodstream.</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose is carried away by the bloodstream to various tissues and organs for utilization.</span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-152428.png\" style=\"height:425px; width:500px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Primary active transport:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Involves direct use of ATP for the movement of substances against their concentration gradient and does not apply to glucose absorption in the intestine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Facilitated diffusion:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Passive movement of molecules along their concentration gradient through a membrane protein, applies to the exit of glucose at the basolateral side but not to its uptake at the luminal side.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Any of the above:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Not applicable as the specific mechanism for glucose absorption is secondary active transport.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glucose is absorbed in the intestine through secondary active transport utilizing the Sodium-Glucose Co-Transporter 1 (SGLT1), which couples the energetically favorable transport of sodium with the transport of glucose against its gradient into enterocytes.</span></span></span></p>",
    "correct_choice_id": 27321,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 60491,
    "choices": [
      {
        "id": 241257,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 &rarr; 3 &rarr;2 &rarr; 4</span></span></p>"
      },
      {
        "id": 241258,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 &rarr; 1 &rarr; 2 &rarr; 4</span></span></p>"
      },
      {
        "id": 241259,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 &rarr;<span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 1 </span>&rarr;<span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 4 </span>&rarr;<span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 2</span></span></span></p>"
      },
      {
        "id": 241260,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 &rarr; 3 &rarr; 4 &rarr; 2</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is the correct sequence for the correction of hypospadias? (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urethroplasty</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meatoplasty</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Orthoplasty</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glanuloplasty</span></span></span></li>\r\n</ol>",
    "unique_key": "Q9212626",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822831,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) 3 </span>&rarr;<span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 1 </span>&rarr;<span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 4 </span>&rarr;<span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 2</span> </span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct sequence for the correction of hypospadias is <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 3 </span></strong>&rarr;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 1 </span></strong>&rarr;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 4 </span></strong>&rarr;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 2</span></strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The main principles of surgery in hypospadias, in sequence, include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Orthoplasty</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Corrects chordee (the abnormal curvature of the penis), which is the first step in the procedure to ensure proper straightening of the penis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urethroplasty</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Repositioning and tubularization of the urethra to ensure the proper opening at the distal end of the penis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glanuloplasty</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Reconstruction of the glans, forming the tip of the penis and covering the urethral opening.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meatoplasty</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Reconstruction of the distal urethral meatus, which is the final step to ensure a functional and anatomically correct urethral opening.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypospadias is the most common <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">congenital abnormality of the urethra</span></strong>. It is characterized by a <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ventrally placed urethral meatus</span></strong>, a hooded foreskin, and ventral chordee (bending of the penis). The correction aims to restore both functional and cosmetic normality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This sequence places urethroplasty first, which is incorrect because chordee (orthoplasty) needs to be corrected first to ensure proper straightening before other steps.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a common but incorrect option, as it places urethroplasty before glanuloplasty, while glans reconstruction should be done before distal urethral meatoplasty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The sequence is incorrect, placing urethroplasty and orthoplasty in the wrong order.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct sequence for hypospadias repair is <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">orthoplasty</span></strong> first (to correct chordee), followed by <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">urethroplasty</span></strong>, <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">glanuloplasty</span></strong>, and finally <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">meatoplasty</span></strong> to reconstruct the urethral opening.</span></span></p>",
    "correct_choice_id": 241259,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11183,
    "choices": [
      {
        "id": 44698,
        "text": "<p><span style=\"font-size:18px;\">Selection</span></p>"
      },
      {
        "id": 44699,
        "text": "<p><span style=\"font-size:18px;\">Analysis</span></p>"
      },
      {
        "id": 44700,
        "text": "<p><span style=\"font-size:18px;\">Randomization</span></p>"
      },
      {
        "id": 44701,
        "text": "<p><span style=\"font-size:18px;\">Abstraction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A researcher in epidemiology is planning to conduct a meta-analysis to better understand the effects of a specific intervention. While he lists the various stages and processes associated with a meta-analysis, he includes one element that isn't typically involved in a meta-analysis. Which of the following isn't directly associated with the process of a meta-analysis?&nbsp;</strong><i><strong>[INICET NOV 2021]</strong></i></span></p>",
    "unique_key": "Q4235841",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822665,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Randomization&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Randomization</strong> is not a part of the meta-analysis process but is a critical component of randomized controlled trials (RCTs), which may be included in a meta-analysis.</span></li><li><span style=\"font-size:18px;\">Meta-analysis involves analysis of multiple studies together.</span></li><li><span style=\"font-size:18px;\">Steps of Meta-analysis involves Hypothesis formation, Study selection, Formulation of data, Analysis of data, examining bias, formulating conclusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/666.jpg\" alt=\"\" width=\"900\" height=\"394\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Selection</strong>: Involves selecting studies for inclusion in the meta-analysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Analysis</strong>: Involves statistical analysis of the combined data from the selected studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Abstraction</strong>: Involves extracting data from the studies for inclusion in the meta-analysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Randomization is a part of conducting individual randomized controlled trials, not the process of performing a meta-analysis.</span></li></ul>",
    "correct_choice_id": 44700,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5855,
    "choices": [
      {
        "id": 23390,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CMV</span></span></span></p>"
      },
      {
        "id": 23391,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus</span></span></span></p>"
      },
      {
        "id": 23392,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toxoplasma</span></span></span></p>"
      },
      {
        "id": 23393,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is the cause of Hydrops fetalis?&nbsp;</span></span>&nbsp;(INICET MAY 2019)</p>",
    "unique_key": "Q7900777",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822829,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Parvovirus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 is the most common infectious cause of hydrops fetalis. (Non immune hydrops)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 infects fetal erythroid progenitor cells and causes anemia. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe anemia leads to high-output cardiac failure and hydrops fetalis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. CMV</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Typically causes peri-ventricular calcifications in the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Toxoplasmosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Causes:&nbsp; hydrocephalus, chorioretinitis, cerebral calcification, microcephaly, seizures and mental retardation in the newborn.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. HIV</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vertical transmission of HIV from mother to infant can occur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 is the most common infectious cause of hydrops fetalis due to its effect on fetal erythroid progenitor cells, leading to severe anemia and subsequent high-output cardiac failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 347, DC Dutta&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
    "correct_choice_id": 23391,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63636,
    "choices": [
      {
        "id": 253749,
        "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-c, 3-a, 4-b</span></p>"
      },
      {
        "id": 253750,
        "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-a, 3-d, 4-b</span></p>"
      },
      {
        "id": 253751,
        "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-d, 3-c, 4-a</span></p>"
      },
      {
        "id": 253752,
        "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-b, 3-d, 4-c</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the following ocular drugs with respect to their side effects:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Column A:</strong></span></p><p><span style=\"font-size:12.0pt;\">1. Amiodarone&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">2. Digoxin</span></p><p><span style=\"font-size:12.0pt;\">3. Systemic steroids&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">4. Hydroxychloroquine</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Column B:</strong></span></p><p><span style=\"font-size:12.0pt;\">A. Cataract</span></p><p><span style=\"font-size:12.0pt;\">B. Retinopathy</span></p><p><span style=\"font-size:12.0pt;\">C. Yellow vision</span></p><p><span style=\"font-size:12.0pt;\">D. Corneal microdeposits</span></p>",
    "unique_key": "Q6932943",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822851,
    "difficulty_level": "intermediate",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1-d, 2-c, 3-a, 4-b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The correct matches of the drugs with their side effects are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Amiodarone: d. Corneal microdeposits</strong></span><br><span style=\"font-size:16px;\">Amiodarone leads to the formation of whorl-like corneal microdeposits, also known as&nbsp;cornea verticillata or&nbsp;vortex keratopathy. These appear as gray or brown opacities in a whorled pattern on the corneal surface. The mechanism is related to the drug\u2019s accumulation within the corneal epithelium due to its lipid affinity. Typically, these deposits are asymptomatic, but in some cases, patients may experience visual disturbances. Other medications, such as chloroquine, phenothiazines, and indomethacin, can also cause similar deposits.</span></li><li><span style=\"font-size:16px;\"><strong>Digoxin: c. Yellow vision (Xanthopsia)</strong></span><br><span style=\"font-size:16px;\">Digoxin is known to cause xanthopsia, where the vision takes on a yellowish hue. This side effect is due to the drug\u2019s action on the retina and visual pathways, altering color perception. Yellow vision is a common sign of digoxin toxicity, and other associated symptoms can include blurred vision and visual disturbances.</span></li><li><span style=\"font-size:16px;\"><strong>Systemic steroids: a. Cataract</strong></span><br><span style=\"font-size:16px;\">Prolonged use of systemic steroids can lead to the development of cataracts, particularly&nbsp;posterior subcapsular cataracts. These cataracts form at the back of the lens and are more likely to impair vision compared to other types. The mechanism involves changes in lens protein structure and oxidative damage. In contrast, topical steroids are more often associated with increased intraocular pressure and glaucoma.</span></li><li><span style=\"font-size:16px;\"><strong>Hydroxychloroquine: b. Retinopathy</strong></span><br><span style=\"font-size:16px;\">Hydroxychloroquine can result in toxic retinopathy, which damages the retinal layers, especially the macula. In the initial stages, retinal damage may not be visible on examination. As the condition progresses, a characteristic&nbsp;bull\u2019s eye maculopathy can be seen, which features central pigmentation surrounded by a ring of depigmentation. This is due to the drug\u2019s accumulation in the retina, where it binds to melanin and disrupts the function of photoreceptors.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The key drug-specific ocular side effects: Amiodarone causes corneal microdeposits, Digoxin leads to yellow vision, systemic steroids can cause cataracts, and Hydroxychloroquine is linked with toxic retinopathy.</span></p>",
    "correct_choice_id": 253749,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54667,
    "choices": [
      {
        "id": 218133,
        "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4, E-5</span></p>"
      },
      {
        "id": 218134,
        "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-4, D-3, E-5</span></p>"
      },
      {
        "id": 218135,
        "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-1, C-3, D-5, E-4</span></p>"
      },
      {
        "id": 218136,
        "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-1, C-3, D-4, E-5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the following&nbsp;</span>(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-102003.png\" alt=\"\" width=\"1000\" height=\"281\"></span></p>",
    "unique_key": "Q1584688",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822859,
    "difficulty_level": "beginner",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) A-2, B-1, C-3, D-4, E-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct matching of the items is as follows:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Eonism (Transvestism)</strong>: Wearing clothes of the opposite sex, often for sexual gratification or due to gender identity disorder.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Frotteurism</strong>: The act of rubbing one's genitals against another person, usually in a crowded place.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Necrophilia</strong>: Engaging in sexual activity with dead bodies.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exhibitionism</strong>: The act of exposing one's genitalia to unsuspecting individuals.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Passive Algoglenia</strong>: Deriving sexual gratification from experiencing pain, also known as masochism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eonism (Transvestism) is wearing clothes of the opposite sex, Frotteurism is rubbing genitals against another person, Necrophilia is having sex with dead bodies, Exhibitionism is exposing genitalia to unsuspecting individuals, and Passive Algoglenia is gratification from experiencing pain.</span></p>",
    "correct_choice_id": 218136,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5802,
    "choices": [
      {
        "id": 23179,
        "text": "<p><span style=\"font-size:12pt;\">Pituitary dysfunction</span></p>"
      },
      {
        "id": 23180,
        "text": "<p><span style=\"font-size:12pt;\">Ovarian dysfunction</span></p>"
      },
      {
        "id": 23181,
        "text": "<p><span style=\"font-size:12pt;\">First pregnancy</span></p>"
      },
      {
        "id": 23182,
        "text": "<p><span style=\"font-size:12pt;\">Uterine synechiae</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A young female has history of a induced abortion at 11 weeks. She has had amenorrhea since then. Her FSH now is 6 mlU/ml. Which of the following can be a cause for her amenorrhea?&nbsp;(INICET MAY 2018)</span></p>",
    "unique_key": "Q4084365",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822860,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Uterine synechiae</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Secondary amenorrhea following a spontaneous abortion and subsequent dilation and curettage (D&amp;C) is typically due to intrauterine adhesions, also known as Asherman syndrome.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Uterine Synechiae (Asherman Syndrome):</strong> This condition involves the formation of scar tissue within the uterine cavity, leading to amenorrhea or menstrual abnormalities. It commonly occurs after uterine surgeries like D&amp;C.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Diagnosis:</strong> Hysteroscopy is the gold standard for diagnosing Asherman syndrome.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment:</strong> Hysteroscopic adhesiolysis is the treatment to remove the adhesions and restore normal uterine cavity function.</span></li></ul></li></ul><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Pituitary dysfunction:</strong> This would typically be associated with abnormal levels of pituitary hormones, including FSH. The normal FSH level (6 mIU/ml) suggests that pituitary function is intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ovarian dysfunction:</strong> This condition would generally present with elevated or depressed levels of FSH and other ovarian hormones. The normal FSH level suggests that ovarian function is likely normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. First pregnancy:</strong> In pregnancy, FSH levels are very low (&lt;0.1 mIU/ml). The FSH level of 6 mIU/ml makes this an unlikely cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Secondary amenorrhea following a history of spontaneous abortion and D&amp;C is usually due to intrauterine adhesions (Asherman syndrome), diagnosed by hysteroscopy and treated with hysteroscopic adhesiolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 459, DC Dutta\u2019s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
    "correct_choice_id": 23182,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4188,
    "choices": [
      {
        "id": 16731,
        "text": "<p><span style=\"font-size:12.0pt;\">Sclerotic body</span></p>"
      },
      {
        "id": 16732,
        "text": "<p><span style=\"font-size:12.0pt;\">Budding yeast</span></p>"
      },
      {
        "id": 16733,
        "text": "<p><span style=\"font-size:12.0pt;\">Negri body</span></p>"
      },
      {
        "id": 16734,
        "text": "<p><span style=\"font-size:12.0pt;\">Asteroid body</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the pathognomonic structure in the slide given below?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-68.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p>",
    "unique_key": "Q1420575",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822669,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Sclerotic body</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The histopathological picture shows brown coloured thick walled round cells that have transverse septations within them. These are called as Sclerotic bodies, also known as muriform cells or Medlar bodies, or copper penny appearance a found in tissue biopsies of patients with chromoblastomycosis. These bodies are a key diagnostic feature of this fungal infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/untitled-296.jpg\" alt=\"\" width=\"300\" height=\"230\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Budding yeast</strong>: This is a general term for yeast cells reproducing through budding. It is not pathognomonic for a specific disease without further context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Negri bodies</strong> are intracytoplasmic, round purplish structures with basophilic inner granules. They are pathognomic of rabies.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/28/screenshot-2024-06-28-170613.png\" alt=\"\" width=\"300\" height=\"267\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Asteroid bodies</strong> are oval, basophilic structure with eosinophilic radiation. They are antigen-antibody complexes deposits. Seen in sporotricosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/untitled-298.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Few Important Pathognomonic structures associated with disease:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/pathognomonic-structure_page_1.jpg\" alt=\"\" width=\"1000\" height=\"1704\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/pathognomonic-structure_page_2.jpg\" alt=\"\" width=\"1000\" height=\"1689\"></strong></span></p>",
    "correct_choice_id": 16731,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5854,
    "choices": [
      {
        "id": 23386,
        "text": "<p><span style=\"font-size:12pt;\">Gardasil</span></p>"
      },
      {
        "id": 23387,
        "text": "<p><span style=\"font-size:12pt;\">Biovac</span></p>"
      },
      {
        "id": 23388,
        "text": "<p><span style=\"font-size:12pt;\">Rabivac</span></p>"
      },
      {
        "id": 23389,
        "text": "<p><span style=\"font-size:12pt;\">Tvac</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old unmarried female has come to the gynae OPD for cervical cancer vaccination. Which is preferred?</span>&nbsp;(INICET MAY 2019)</p>",
    "unique_key": "Q3408412",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822835,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Gardasil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is the preferred vaccine for cervical cancer prevention. It is a quadrivalent HPV vaccine that provides protection against four serotypes of the Human Papillomavirus (HPV): 6, 11, 16, and 18.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>HPV Serotypes Covered by Gardasil:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>6 and 11:</strong> These types are associated with anogenital warts.</span></li><li><span style=\"font-size:12pt;\"><strong>16 and 18:</strong> These types are linked to cervical cancer and other HPV-related cancers.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is administered as an intramuscular injection with a recommended schedule of three doses (0, 2, and 6 months).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Available HPV Vaccines:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Cervarix (Bivalent):</strong> Covers HPV serotypes 16 and 18.</span></li><li><span style=\"font-size:12pt;\"><strong>Gardasil (Quadrivalent):</strong> Covers HPV serotypes 6, 11, 16, and 18.</span></li><li><span style=\"font-size:12pt;\"><strong>Gardasil 9 (Nonavalent or HPV9):</strong> Covers HPV serotypes 6, 11, 16, 18, 31, 33, 45, 52, and 58.</span></li><li><span style=\"font-size:12pt;\"><strong>Cervavac (India\u2019s indigenous HPV vaccine):</strong> Quadrivalent, covers serotypes 6, 11, 16, and 18.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Biovac:</strong> This is a vaccine for Hepatitis A, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rabivac:</strong> This is a rabies vaccine for animals, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Tvac:</strong> This is a tetanus vaccine, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is the preferred vaccine for preventing cervical cancer and related HPV diseases, covering serotypes 6, 11, 16, and 18.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)</u></strong></span></a></p>",
    "correct_choice_id": 23386,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55887,
    "choices": [
      {
        "id": 222981,
        "text": "<p><span style=\"font-size:12.0pt;\">Proprioception</span></p>"
      },
      {
        "id": 222982,
        "text": "<p><span style=\"font-size:12.0pt;\">Touch</span></p>"
      },
      {
        "id": 222983,
        "text": "<p><span style=\"font-size:12.0pt;\">Pain</span></p>"
      },
      {
        "id": 222984,
        "text": "<p><span style=\"font-size:12.0pt;\">Vibration</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which type of sensation is carried by the 2nd order neuron of the spinal nucleus of the trigeminal nerve ? (INICET MAY 2024)</span></p>",
    "unique_key": "Q6945529",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822857,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) Pain</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The spinal nucleus of the trigeminal nerve is responsible for transmitting pain and temperature sensations from the face to the brain. The second-order neurons in this nucleus relay these sensations to higher brain centers for processing. This pathway is crucial for the perception of painful stimuli and temperature changes, ensuring appropriate responses to potential dangers or injuries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note -</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The trigeminal nerve has two types of nuclei: a motor nucleus and sensory nuclei.</span></li><li><span style=\"font-size:12.0pt;\">The motor nucleus is singular and located in the pons.</span></li><li><span style=\"font-size:12.0pt;\">The sensory nuclei are more numerous, consisting of three different nuclei distributed within the brainstem:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Mesencephalic Nucleus of the Trigeminal Nerve (MNT)</strong>: This nucleus is situated in the midbrain and is part of the sensory nuclei.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Chief Sensory Nucleus of the Trigeminal Nerve (CNT)</strong>: Located in the pons, this nucleus primarily handles the main sensory functions of the trigeminal nerve.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Spinal Nucleus of the Trigeminal Nerve (also referred to as SNT)</strong>: This extends down to the medulla and is involved with transmitting pain and temperature sensations from the face to the brain.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Four nuclei: (3 sensory +1 Motor).</span></li><li><span style=\"font-size:12.0pt;\">General somatic afferent:</span><ol><li><span style=\"font-size:12.0pt;\">Mesencephalic (midbrain &amp; pons): receives proprioceptive fibers from face</span></li><li><span style=\"font-size:12.0pt;\">Principal (main) sensory (pons): receives touch fibers from face.</span></li><li><span style=\"font-size:12.0pt;\">Spinal (pons, medulla &amp; upper 2-3 cervical segments of spinal cord): receives pain &amp; temperature sensations from face.</span></li></ol></li><li><span style=\"font-size:12.0pt;\">Special visceral efferent:</span></li></ul><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">4. Motor nucleus (pons): supplies:</span></p><ul><li><span style=\"font-size:12.0pt;\">Four muscles of mastication (temporalis, masseter, medial &amp; lateral pterygoid).</span></li><li><span style=\"font-size:12.0pt;\">Other four muscles (Anterior belly of diagstic, mylohyoid, tensor tympani &amp; tensor palati).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/untitled-6_01aPAfq.jpg\" alt=\"\" width=\"641\" height=\"859\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Proprioception</strong>: Proprioception is managed by the mesencephalic nucleus of the trigeminal nerve, not the spinal nucleus. This nucleus is responsible for sensing the position and movement of the jaw muscles, contributing to reflexes such as the jaw jerk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Touch</strong>: The chief sensory nucleus of the trigeminal nerve handles the sensation of touch. This nucleus receives tactile information from the face and transmits it to the brain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vibration</strong>: Vibration sense is also managed by the chief sensory nucleus of the trigeminal nerve. This nucleus is involved in processing detailed touch and vibratory sensations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The spinal nucleus of the trigeminal nerve carries pain and temperature sensations, distinguishing it from the other nuclei responsible for proprioception, touch, and vibration.</span></p>",
    "correct_choice_id": 222983,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 31832,
    "choices": [
      {
        "id": 127198,
        "text": "<p><span style=\"font-size:12pt;\">Propranolol</span></p>"
      },
      {
        "id": 127199,
        "text": "<p><span style=\"font-size:12pt;\">Lugol\u2019s Iodine</span></p>"
      },
      {
        "id": 127200,
        "text": "<p><span style=\"font-size:12pt;\">Acetaminophen</span></p>"
      },
      {
        "id": 127201,
        "text": "<p><span style=\"font-size:12pt;\">Aspirin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the management of a thyroid storm, a critical and life-threatening condition due to an excess of thyroid hormone, a variety of medications are used to control the symptoms and the overactive thyroid. Which of the following drugs is not typically used in the treatment of thyroid storm?&nbsp;(INICET NOV 2023)</span></p>",
    "unique_key": "Q8018904",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822850,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Aspirin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Aspirin is avoided in thyroid storm because it can displace thyroid hormones from their binding proteins, potentially increasing the levels of active thyroid hormone in the blood and exacerbating the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thyroid storm is a severe hypermetabolic state caused by an excessive release of thyroid hormones (thyrotoxicosis). The standard treatment includes:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Propranolol: </strong>Propranolol is a non-selective beta-blocker that is used to manage the sympathetic symptoms of thyrotoxicosis like tachycardia, tremors, and anxiety. It also inhibits the peripheral conversion of T4 to the more active T3.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Lugol\u2019s Iodine: </strong>Lugol's Iodine is given to decrease the synthesis and release of thyroid hormones. The high iodine content temporarily inhibits the synthesis of thyroid hormones (the Wolff-Chaikoff effect) and blocks their release into the circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Acetaminophen: </strong>Acetaminophen (paracetamol) is preferred for fever control in thyroid storm. It does not have the anti-inflammatory properties that might interfere with thyroid hormone levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Aspirin is not used in the treatment of thyroid storm because it can increase free thyroid hormone levels by displacing thyroid hormones from their binding proteins, potentially worsening the condition.</span></p>",
    "correct_choice_id": 127201,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 43264,
    "choices": [
      {
        "id": 172723,
        "text": "<p><span style=\"font-size:12pt;\">Opium</span></p>"
      },
      {
        "id": 172724,
        "text": "<p><span style=\"font-size:12pt;\">Marijuana</span></p>"
      },
      {
        "id": 172725,
        "text": "<p><span style=\"font-size:12pt;\">Cocaine</span></p>"
      },
      {
        "id": 172726,
        "text": "<p><span style=\"font-size:12pt;\">Magic mushroom</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">In 18<sup>th</sup> century British East India company used to transport which substance of abuse to China:&nbsp;</span>(INICET NOVEMBER 2023)</p>",
    "unique_key": "Q4310734",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822670,
    "difficulty_level": "beginner",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Opium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Opium is derived from the poppy plant and has been used both medicinally and recreationally. In the 18th and 19th centuries, the British East India Company exported vast quantities of opium to China, leading to widespread addiction and the Opium Wars, which had significant geopolitical consequences.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Marijuana</strong>: A psychoactive drug from the Cannabis plant, used both recreationally and medicinally around the world.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cocaine</strong>: Derived from the coca plant, cocaine is a powerful stimulant used primarily as a recreational drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Magic Mushrooms</strong>: Refer to various types of mushrooms that contain psilocybin, a psychoactive compound. These have been used for centuries for their hallucinogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>In 18<sup>th</sup> century British East India company used to transport opium to China.</strong></span></p>",
    "correct_choice_id": 172723,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73225,
    "choices": [
      {
        "id": 291857,
        "text": "<p><span style=\"font-size:12.0pt;\">Golgi apparatus</span></p>"
      },
      {
        "id": 291858,
        "text": "<p><span style=\"font-size:12.0pt;\">ER</span></p>"
      },
      {
        "id": 291859,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitochondria</span></p>"
      },
      {
        "id": 291860,
        "text": "<p><span style=\"font-size:12.0pt;\">Disc&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not seen in an inner segment of the photoreceptor? (INICET NOV 2024)</span></p>",
    "unique_key": "Q1251614",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822672,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Disc&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Disc membranes are specifically located in the<strong> outer segment of the photoreceptor, not the inner segment. The inner segment contains&nbsp;</strong>most cellular organelles, including<strong>:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Mitochondria</strong></span></li><li><span style=\"font-size:16px;\"><strong>Endoplasmic reticulum (ER)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Golgi apparatus</strong></span></li><li><span style=\"font-size:16px;\"><strong>Nucleus</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">The outer segment is characterized by the<strong> presence of disc membranes,&nbsp;</strong>which are crucial for<strong> phototransduction.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2iR9Pf6.png\" width=\"1062\" height=\"847\"></strong></span></p>",
    "correct_choice_id": 291860,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11460,
    "choices": [
      {
        "id": 45806,
        "text": "<p><span style=\"font-size:12.0pt;\">Cryoglobulinemic vasculitis</span></p>"
      },
      {
        "id": 45807,
        "text": "<p><span style=\"font-size:12.0pt;\">Polyarteritis nodosa</span></p>"
      },
      {
        "id": 45808,
        "text": "<p><span style=\"font-size:12.0pt;\">EGPA</span></p>"
      },
      {
        "id": 45809,
        "text": "<p><span style=\"font-size:12.0pt;\">Giant cell arteritis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A triad of skin lesions, asymmetric mononeuritis multiplex and eosinophilia is seen in which of the following conditions? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q2949063",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822848,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) EGPA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, is characterized by a combination of <strong>asthma, eosinophilia, and vasculitis </strong>affecting multiple organ systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical triad of skin lesions (such as purpura or nodules), asymmetric mononeuritis multiplex (manifesting as numbness, pain, or muscle weakness typically in the limbs), and eosinophilia is highly suggestive of this condition. EGPA is a type of ANCA-associated vasculitis but differs from others in its prominent eosinophilic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cryoglobulinemic vasculitis:&nbsp;</strong>Typically associated with hepatitis C infection and features immune complexes in the blood that precipitate in the cold. It commonly presents with palpable purpura, joint pains, and kidney involvement but not typically with eosinophilia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Polyarteritis nodosa (PAN):&nbsp;</strong>A medium vessel vasculitis that may present with similar features including neuropathy and skin lesions but does not typically include eosinophilia as a prominent feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Giant cell arteritis (GCA):&nbsp;</strong>Primarily affects large vessels, particularly the temporal arteries, and presents with symptoms such as headache, jaw claudication, and potential blindness. It does not feature the triad of skin lesions, mononeuritis multiplex, and eosinophilia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">EGPA is a distinctive form of vasculitis marked by asthma, eosinophilia, and a systemic vasculitis involving skin and nerves among other systems. Its recognition is crucial due to the need for early and aggressive treatment to prevent significant morbidity and mortality.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture55.jpg\" alt=\"\" width=\"1000\" height=\"554\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Rheumatology/Vasculitis/Chap 363</strong></span></p>",
    "correct_choice_id": 45808,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 2860,
    "choices": [
      {
        "id": 11425,
        "text": "<p><span style=\"font-size:12.0pt;\">A, C, E</span></p>"
      },
      {
        "id": 11426,
        "text": "<p><span style=\"font-size:12.0pt;\">B, D</span></p>"
      },
      {
        "id": 11427,
        "text": "<p><span style=\"font-size:12.0pt;\">B, A, C</span></p>"
      },
      {
        "id": 11428,
        "text": "<p><span style=\"font-size:12.0pt;\">D, B, E</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">True regarding mitochondrial DNA? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2021)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Higher chances of mutations as compared to the nuclear genome</span></li><li><span style=\"font-size:12.0pt;\">Single stranded Circular DNA</span></li><li><span style=\"font-size:12.0pt;\">mt codons are slightly different from nuclear DNA codons</span></li><li><span style=\"font-size:12.0pt;\">mtDNA encodes for all the ETC complex proteins</span></li><li><span style=\"font-size:12.0pt;\">Has around 16,000 base pairs</span></li></ol>",
    "unique_key": "Q4835016",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822667,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A, C, E</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>MITOCHONDRIAL DNA&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement A. Higher chances of mutations as compared to the nuclear genome:</strong> mtDNA has a higher mutation rate compared to nuclear DNA due to the lack of introns and protective histone proteins, which help prevent mutations in nuclear DNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement C. mt codons are slightly different from nuclear DNA codons:&nbsp;</strong>mtDNA uses a slightly different genetic code. For example, the codon UGA, which is a stop codon in the universal genetic code, codes for tryptophan in mtDNA. Similarly, AGG and AGA code for arginine in the universal genetic code but are stop codons in mtDNA. AUA codes for isoleucine in the universal genetic code but codes for methionine in mtDNA.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-103550.jpg\" alt=\"\" width=\"1000\" height=\"363\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement E. Has around 16,000 base pairs:</strong> mtDNA contains approximately 16,000 base pairs and 37 genes, which make up about 1% of the total cellular DNA.</span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement B. Single stranded Circular DNA:</strong> This statement is incorrect. mtDNA is circular but double-stranded.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement D. mtDNA encodes for all the ETC complex proteins:</strong> This statement is incorrect. mtDNA encodes for only 13 of the 67 proteins required for the electron transport chain (ETC), which is approximately 19% of the total.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitochondrial DNA has a higher mutation rate compared to nuclear DNA, has a slightly different genetic code, and contains around 16,000 base pairs, encoding for a portion but not all of the proteins required for the electron transport chain.</span></p>",
    "correct_choice_id": 11425,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 71739,
    "choices": [
      {
        "id": 285965,
        "text": "<p><span style=\"font-size:16px;\">Fracture risk assessment&nbsp;</span></p>"
      },
      {
        "id": 285966,
        "text": "<p><span style=\"font-size:16px;\">Fracture rehabilitation assessment&nbsp;</span></p>"
      },
      {
        "id": 285967,
        "text": "<p><span style=\"font-size:16px;\">Fracture repair assessment</span></p>"
      },
      {
        "id": 285968,
        "text": "<p><span style=\"font-size:16px;\">Fracture reduction assessment</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">FRAX is related to: (INICET NOV 2024)</span></p>",
    "unique_key": "Q9469753",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822834,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Fracture risk assessment&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>FRAX or Fracture Risk Assessment Tool</strong>, is a screening tool that provides country-specific algorithms for estimating individualized <strong>10-year probability of hip and major osteoporotic fracture</strong>&nbsp;and to target anti-osteoporosis treatments.&nbsp;</span></li><li><span style=\"font-size:16px;\">It was created in 2008 at the University of Sheffield in the United Kingdom by the WHO Collaborating Centre for Metabolic Bone Diseases.</span></li><li><span style=\"font-size:16px;\">Many risk factors for fractures were identified and added to the tool through a series of comprehensive meta-analyses from 12 prospective population-based studies from North America, Europe, Asia, and Australia.&nbsp;</span></li><li><span style=\"font-size:16px;\">FRAX uses <strong>7 easily accessible clinical risk factors</strong>, which are entered into the calculation as yes or no.&nbsp;</span></li><li><span style=\"font-size:16px;\">These factors include smoking, systemic glucocorticoid usage, excessive alcohol consumption, rheumatoid arthritis, parental hip fractures, past fragility fractures, and other causes of secondary osteoporosis.&nbsp;</span></li><li><span style=\"font-size:16px;\">FRAX also takes into account body mass index (BMI), sex, and age.&nbsp;</span></li><li><span style=\"font-size:16px;\">FRAX may calculate the fracture probability with or without femoral neck BMD, accommodating different situations.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-14%20122531.jpg\" width=\"964\" height=\"710\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Fracture rehabilitation assessment:&nbsp;</strong>Rehabilitation focuses on restoring function and movement after a fracture has occurred. FRAX is used before a fracture, to predict the likelihood of one happening in the future.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Fracture repair assessment:&nbsp;</strong>Repair refers to the medical procedures (like surgery) used to fix a broken bone. FRAX is about predicting the risk of a fracture, not how it will be treated.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Fracture reduction assessment:&nbsp;</strong>Reduction is the process of setting a broken bone back into its proper alignment. FRAX doesn't assess the need for reduction, but rather the overall risk of a fracture occurring in the first place.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">FRAX is a tool for prevention by identifying those at risk of fractures.</span></li></ul>",
    "correct_choice_id": 285965,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24738,
    "choices": [
      {
        "id": 98913,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 98914,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 98915,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
      },
      {
        "id": 98916,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What characteristics define necrosis among the options provided?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Disrupted cell membrane</span></li><li><span style=\"font-size:12.0pt;\">Induces inflammation</span></li><li><span style=\"font-size:12.0pt;\">Swelling of the cell</span></li><li><span style=\"font-size:12.0pt;\">Can be seen physiologically</span></li></ol>",
    "unique_key": "Q3905506",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822836,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Necrosis</strong> is a form of cell injury that results in the premature death of cells in living tissue by autolysis. The following are the key characteristics of necrosis:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Disrupted cell membrane</strong>: Necrosis is characterized by the loss of cell membrane integrity, leading to the uncontrolled release of cellular contents into the extracellular space.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Induces inflammation</strong>: The release of cellular contents into the surrounding tissue causes an inflammatory response. This is a hallmark of necrosis, as the body reacts to the injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Swelling of the cell</strong>: In necrosis, cells typically swell and eventually rupture due to the loss of membrane integrity and the influx of water and ions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Necrosis is never physiological</strong>: it always occurs as a result of pathological conditions. Unlike apoptosis, which is a programmed and regulated form of cell death, necrosis is unregulated and is usually detrimental to the organism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-173332.png\" alt=\"\" width=\"1000\" height=\"550\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-125696.jpg\" alt=\"\" width=\"700\" height=\"347\"></u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>FEATURES OF NECROSIS</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-125694.jpg\" alt=\"\" width=\"1000\" height=\"306\"></u></strong></span></p>",
    "correct_choice_id": 98914,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74764,
    "choices": [
      {
        "id": 297965,
        "text": "<p><span style=\"font-size:16px;\">Phosphorus</span></p>"
      },
      {
        "id": 297966,
        "text": "<p><span style=\"font-size:16px;\">Arsenic</span></p>"
      },
      {
        "id": 297967,
        "text": "<p><span style=\"font-size:16px;\">Mercury</span></p>"
      },
      {
        "id": 297968,
        "text": "<p><span style=\"font-size:16px;\">Lead</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">This powder is used in treatment of which poisoning? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6DWFjdh.png\" width=\"368\" height=\"249\"></span></p>",
    "unique_key": "Q4629617",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822659,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Phosphorus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The blue-colored powder referred to is copper sulfate (blue vitriol), which was historically used to treat phosphorus poisoning. Copper sulfate reacts with phosphorus to form cupric phosphide, which is non-toxic. While copper sulfate is no longer commonly used as an antidote due to its own toxicity, it remains a historically important treatment. The antidotes for phosphorus poisoning include KMnO4 (potassium permanganate) and CuSO4 (copper sulfate).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Arsenic:</strong> Incorrect. Arsenic poisoning is treated with chelating agents like DMPS (Dimercapto propanesulfonic acid), Dimercaprol (BAL), or Succimer (DMSA). Copper sulfate is not used in arsenic poisoning treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Mercury:&nbsp;</strong>Incorrect. Mercury poisoning is treated with chelating agents like Dimercaprol, DMPS, or Succimer. Copper sulfate has no role in mercury poisoning treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Lead:</strong> Incorrect. Lead poisoning is primarily treated with Dimercaprol + CaNa2EDTA, DMPS, or Succimer. Copper sulfate is not used in lead poisoning treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Copper Sulphate (blue vitriol) was historically used to treat phosphorus poisoning but is no longer recommended due to its own toxicity. The current antidotes for phosphorus poisoning include <strong>KMnO\u2084 (Potassium Permanganate) and Copper Sulphate</strong>, although clinical use has largely been discontinued\u200b.</span></p>",
    "correct_choice_id": 297965,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11154,
    "choices": [
      {
        "id": 44582,
        "text": "<p><span style=\"font-size:18px;\">Worm infestation</span></p>"
      },
      {
        "id": 44583,
        "text": "<p><span style=\"font-size:18px;\">Vitamin A deficiency</span></p>"
      },
      {
        "id": 44584,
        "text": "<p><span style=\"font-size:18px;\">Scabies</span></p>"
      },
      {
        "id": 44585,
        "text": "<p><span style=\"font-size:18px;\">Filariasis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 33-year-old public health officer is assigned to lead a healthcare team aiming to address and manage endemic conditions in a remote village with limited healthcare access. As part of the initiative, there's a proposal to start a mass drug administration (MDA) program targeting common health concerns in the area. Which of the following conditions would NOT traditionally be managed through mass drug administration? </strong><i><strong>[AIIMS NOV 2019]</strong></i></span></p>",
    "unique_key": "Q1044570",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822654,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Vitamin A deficiency&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Mass Drug Administration (MDA) refers to providing a drug to an entire population without considering age and gender.</span></li><li><span style=\"font-size:18px;\">Vitamin A prophylaxis is exclusively administered as per the National Immunization Schedule (NIS) to children up to the age of 5.</span></li><li><span style=\"font-size:18px;\">This prophylactic treatment is not intended as a curative measure but rather as a preventive measure.</span></li><li><span style=\"font-size:18px;\">Treatment with vitamin A is reserved solely for children displaying symptoms of vitamin A deficiency, and such treatment is not widespread throughout the community.</span></li><li><span style=\"font-size:18px;\">As a result, it is not categorized as part of Mass Drug Administration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Worm infestation:&nbsp;</strong>Managed through MDA using albendazole or mebendazole to treat and prevent worm infestations in the population.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Scabies:&nbsp;</strong>Managed through MDA using ivermectin to treat and prevent scabies outbreaks in the community.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Filariasis:&nbsp;</strong>Managed through MDA using DEC (diethylcarbamazine) and albendazole to prevent and control filariasis in endemic areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Vitamin A deficiency is managed through targeted prophylaxis in children rather than mass drug administration.</span></li><li><span style=\"font-size:18px;\">In contrast, MDA is carried out for conditions like scabies (using ivermectin), worm infestations (using albendazole), and filariasis (using DEC + albendazole).</span></li></ul>",
    "correct_choice_id": 44583,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4500,
    "choices": [
      {
        "id": 17976,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Esophageal intubation</span></p>"
      },
      {
        "id": 17977,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Inspiration with cardiac oscillations</span></p>"
      },
      {
        "id": 17978,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Bronchospasm</span></p>"
      },
      {
        "id": 17979,
        "text": "<p><span style=\"color:black;font-size:12pt;\">Spontaneous respiratory effort</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A capnograph obtained from an intubated patient undergoing controlled ventilation is given below. Which of the following is a likely cause of the finding seen? (</span>NEET PG 2020)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/whatsapp-image-2023-06-12-at-190121011010201020.jpg\" alt=\"\" width=\"300\" height=\"141\"></span></p><p>&nbsp;</p>",
    "unique_key": "Q7664525",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822650,
    "difficulty_level": "beginner",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Spontaneous respiratory effort</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The capnograph shows a characteristic pattern known as the curare notch or curare cleft.</span></li><li><span style=\"font-size:12pt;\">This pattern indicates spontaneous inspiratory effort by the patient during controlled mechanical ventilation.</span></li><li><span style=\"font-size:12pt;\">This occurs when the patient attempts to breathe against the ventilator cycle, causing a dip in the capnograph waveform.</span></li><li><span style=\"font-size:12pt;\">The appropriate next step would be to paralyze the patient again by administering an additional dose of muscle relaxant to ensure proper synchronization with the ventilator.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Esophageal intubation:&nbsp;</strong>In cases of esophageal intubation, the capnograph typically shows a very low or absent end-tidal CO2 (EtCO2) reading because the endotracheal tube is not in the trachea, leading to little to no CO2 being detected. The waveform would be almost flat.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture78.jpg\" alt=\"\" width=\"500\" height=\"173\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Inspiration with cardiac oscillations:&nbsp;</strong>Cardiac oscillations can appear on the capnograph as small oscillations or ripples on the expiratory plateau due to the beating of the heart causing minor fluctuations in airway pressure. This is not characterized by a distinct cleft or notch.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/psm-3.jpg\" alt=\"\" width=\"400\" height=\"173\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Bronchospasm:&nbsp;</strong>Bronchospasm causes a \"shark fin\" appearance on the capnograph due to obstructed airflow and prolonged expiration. The waveform would show a slanted, rather than a squared-off, expiratory plateau.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/psm-2.jpg\" alt=\"\" width=\"400\" height=\"164\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A curare notch or cleft on a capnograph indicates spontaneous respiratory effort in a patient who is supposed to be fully ventilated under muscle relaxants, requiring re-administration of the muscle relaxant to ensure proper mechanical ventilation.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Ref: Miller\u2019s Anesthesia, 9<sup>th</sup> Ed. Pg</strong></span><span style=\"font-size:12pt;\"> <strong>1311</strong></span></p>",
    "correct_choice_id": 17979,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3705,
    "choices": [
      {
        "id": 14799,
        "text": "<p><span style=\"font-size:12.0pt;\">Echinococcus multilocularis</span></p>"
      },
      {
        "id": 14800,
        "text": "<p><span style=\"font-size:12.0pt;\">Echinococcus granulosus</span></p>"
      },
      {
        "id": 14801,
        "text": "<p><span style=\"font-size:12.0pt;\">Entamoeba histolvtica</span></p>"
      },
      {
        "id": 14802,
        "text": "<p><span style=\"font-size:12.0pt;\">Cysticercus cellulose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following organisms cause multiple alveolar-like lesions in the liver? (INICET NOV 2019)</span></p>",
    "unique_key": "Q4705226",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822849,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Echinococcus multilocularis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">E. multilocularis leads to alveolar or multilocular hydatid cyst. The <strong>liver is the most commonly affected organ</strong>. The multilocular infiltrating lesion appears like a grossly invasive growth, without any fluid or free brood capsule or scolices which <u>can be mistaken for a malignant tumor</u>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients present with upper quadrant and epigastric pain. <u>Liver enlargement and obstructive jaundice may also be present</u>. It <strong>may also metastasize</strong> to the spleen, lungs and brain in 2% cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The prognosis is very grave and if untreated, <strong>70% cases progress to death.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Surgical resection, when possible, is the best method of treatment</strong>. <u>Albendazole therapy is recommended for 2 years after curative surgery</u>. In those cases, where surgery is not possible, indefinite treatment with albendazole is recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Echinococcus granulosus:</strong> Causes cystic echinococcosis or hydatid disease, which typically involves the formation of fluid-filled cysts rather than alveolar-like lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Entamoeba histolytica:</strong> Causes amoebic liver abscesses, which are different in appearance and pathology from the lesions caused by Echinococcus multilocularis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cysticercus cellulose:</strong> The larval stage of Taenia solium, which causes cysticercosis. It can form cysts in various tissues but does not cause alveolar-like lesions in the liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Echinococcus multilocularis causes multiple alveolar-like lesions in the liver, leading to a serious condition known as alveolar echinococcosis. The prognosis is poor without treatment, emphasizing the importance of early detection and appropriate therapy.</span></p>",
    "correct_choice_id": 14799,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52113,
    "choices": [
      {
        "id": 207953,
        "text": "<p><span style=\"font-size:12.0pt;\">USG contrast agents</span></p>"
      },
      {
        "id": 207954,
        "text": "<p><span style=\"font-size:12.0pt;\">MRI contrast agents</span></p>"
      },
      {
        "id": 207955,
        "text": "<p><span style=\"font-size:12.0pt;\">Iodinated contrast</span></p>"
      },
      {
        "id": 207956,
        "text": "<p><span style=\"font-size:12.0pt;\">CT contrast agent</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which contrast agent is safe in a patient with renal failure? (INICET MAY 2024)</span></p>",
    "unique_key": "Q5833359",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822663,
    "difficulty_level": "beginner",
    "subjects_id": [
      17
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) USG contrast agents</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ultrasound (USG) contrast agents, specifically SONO (sulfur hexafluoride microbubbles), are safe to use in patients with renal failure. These microbubbles are filled with gas and are excreted via the lungs rather than the kidneys, making them suitable for patients with compromised renal function. Unlike other contrast agents, USG contrast agents do not rely on renal clearance, thereby avoiding the risk of further renal damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. MRI contrast agents (Gadolinium-based):</strong> These agents are contraindicated in renal failure due to the risk of nephrogenic systemic fibrosis, a serious condition affecting the skin and internal organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Iodinated contrast:</strong> Commonly used in CT imaging, these agents are contraindicated in renal failure due to the risk of contrast-induced nephropathy, which can further impair renal function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CT contrast agent:</strong> Typically, iodinated contrast is used in CT imaging, which is not safe for patients with renal failure for the reasons mentioned above.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">USG contrast agents, such as SONO (sulfur hexafluoride microbubbles), are the only contrast agents safe for use in patients with renal failure as they are excreted via the lungs and do not rely on renal clearance.</span></p>",
    "correct_choice_id": 207953,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9833,
    "choices": [
      {
        "id": 39299,
        "text": "<p><span style=\"font-size:12.0pt;\">Lymphocyte</span></p>"
      },
      {
        "id": 39300,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibroblast</span></p>"
      },
      {
        "id": 39301,
        "text": "<p><span style=\"font-size:12.0pt;\">Macrophage</span></p>"
      },
      {
        "id": 39302,
        "text": "<p><span style=\"font-size:12.0pt;\">Mast Cell</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Toluidine blue staining is used in the Identification of which of the following cells? </span>(AIIMS MAY 2018)</p>",
    "unique_key": "Q2433591",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822842,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mast Cell</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Toluidine blue is the special stain for mast cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Toluidine blue (also known as tolonium chloride) is an acidophilic metachromatic dye that selectively stains acidic tissue components (sulfates, carboxylates, and phosphate radicals). <strong>Toluidine blue (TB. has an affinity for nucleic acids, and therefore binds to nuclear material of tissues with a high DNA and RNA content.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It also intensely stains some substances leading to a change in color. This effect known as metachromasia.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Orthochromatic Staining</strong> - structures stained blue (Lymphocytes)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Metachromatic Staining</strong> - structures stained dark purple from polymeric aggregates formed when binding to high concentrations of polyanions (Mast cells)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Toluidine blue is often used to identify mast cells by virtue of heparin</strong> (which is very polyanionic. found in their secretion granules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/960.jpg\" alt=\"\" width=\"677\" height=\"303\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Application of Toluidine Blue</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Connective tissue mucins, especially acid mucins. The tissue stains purple to red, while the background is stained blue.</span></li><li><span style=\"font-size:12.0pt;\">Mast cell granules stain purple in color due to the presence of heparin and histamine.</span></li><li><span style=\"font-size:12.0pt;\">Amyloid stain blue but under polarized light they give a bright red birefringence.</span></li><li><span style=\"font-size:12.0pt;\">Endocrine cell granules are stained purple to red.</span></li><li><span style=\"font-size:12.0pt;\">Sulfatides stain red brown or yellow. Only lipids that are sufficiently acidic to induce a metachromatic shift are stained.</span></li><li><span style=\"font-size:12.0pt;\">Corynebacterium diphtheria contains granules with polymerized inorganic polyphosphate, which stains red violet color.</span></li><li><span style=\"font-size:12.0pt;\">Helicobacter stains dark blue against a variably blue background.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lymphocyte</strong>: Lymphocytes can be stained with toluidine blue, but they show orthochromatic staining (blue), not the metachromasia that is characteristic of mast cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fibroblast</strong>: Fibroblasts are not specifically identified by toluidine blue staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Macrophage</strong>: While macrophages can be stained with various dyes, they do not exhibit the metachromasia seen in mast cells with toluidine blue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Toluidine blue&nbsp;</strong>is primarily used to identify <strong>mast cells</strong> due to their characteristic <strong>metachromatic staining</strong> caused by the heparin in their granules.</span></p>",
    "correct_choice_id": 39302,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3788,
    "choices": [
      {
        "id": 15131,
        "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium vivax and falciparum</span></p>"
      },
      {
        "id": 15132,
        "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium ovale and falciparum</span></p>"
      },
      {
        "id": 15133,
        "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium vivax and ovale</span></p>"
      },
      {
        "id": 15134,
        "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium vivax and malariae</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Relapse is seen in? (INICET MAY 2017)</span></p>",
    "unique_key": "Q6888549",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822653,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Plasmodium viva and ovale</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Malaria relapse:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In case of Plasmodium vivax and ovale two kinds of sporozoites are seen, some of which multiply inside hepatic cells to form schizonts and others persist and remain dormant as hypnozoites.</span></li><li><span style=\"font-size:12.0pt;\">True relapse is caused due to hypnozoites (resting forms). Some get activated to become schizonts and release merozoites, which go on infecting RBCs producing clinical relapse.</span></li><li><span style=\"font-size:12.0pt;\">In case of Plasmodium falciparum and malaria, the initial tissue phase disappears completely and no hypnozoites are found, hence relapse is not seen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Plasmodium vivax and falciparum:</strong> While P. vivax can cause relapse, P. falciparum does not form hypnozoites and therefore does not cause relapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Plasmodium ovale and falciparum:</strong> P. ovale can cause relapse due to hypnozoites, but P. falciparum does not form hypnozoites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Plasmodium vivax and malariae:</strong> P. vivax causes relapse due to hypnozoites, but P. malariae does not form hypnozoites and does not cause relapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Relapse in malaria is seen in cases of Plasmodium vivax and Plasmodium ovale due to the presence of hypnozoites, the dormant liver stages that can reactivate and cause renewed infection.</span></p>",
    "correct_choice_id": 15133,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11709,
    "choices": [
      {
        "id": 46802,
        "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline</span></p>"
      },
      {
        "id": 46803,
        "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin</span></p>"
      },
      {
        "id": 46804,
        "text": "<p><span style=\"font-size:12.0pt;\">Chloramphenicol</span></p>"
      },
      {
        "id": 46805,
        "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The drug of choice for treating scrub typhus? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q6418774",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822853,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Doxycycline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Scrub typhus, caused by <i>Orientia tsutsugamushi</i>, is effectively treated with Doxycycline, which is considered the first-line treatment. Doxycycline is administered at a dosage of 100 mg twice daily for 7 to 14 days. It disrupts protein synthesis in the bacterium, which is crucial for its effectiveness against this intracellular pathogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In pregnancy/children- Azithromycin/ chloramphenicol preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ciprofloxacin:&nbsp;</strong>While it is a broad-spectrum antibiotic, it is not the preferred treatment for scrub typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chloramphenicol:&nbsp;</strong>This is an alternative treatment option but is generally reserved for cases where doxycycline or azithromycin cannot be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Azithromycin:&nbsp;</strong>This is a suitable alternative, especially in special populations such as pregnant women and children, where doxycycline is contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Doxycycline is the first-choice medication for treating scrub typhus in adults and non-pregnant women, offering effective relief and eradication of the pathogen when taken for the recommended duration.</span></p>",
    "correct_choice_id": 46802,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9932,
    "choices": [
      {
        "id": 39694,
        "text": "<p><span style=\"font-size:12pt;\">Psoriasis vulgaris</span></p>"
      },
      {
        "id": 39695,
        "text": "<p><span style=\"font-size:12pt;\">Leishmaniasis</span></p>"
      },
      {
        "id": 39696,
        "text": "<p><span style=\"font-size:12pt;\">Mycosis fungoides</span></p>"
      },
      {
        "id": 39697,
        "text": "<p><span style=\"font-size:12pt;\">Pemphigus vulgaris</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">The histopathology picture below is suggestive of? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13496.jpg\" alt=\"\" width=\"300\" height=\"217\"></p>",
    "unique_key": "Q8832810",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822837,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Pemphigus vulgaris</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given slide shows a <strong>row of tombstones' appearance</strong>, which is classically seen in Pemphigus vulgaris.</span></li><li><span style=\"font-size:12pt;\">The production of <strong>antibodies, specifically those against Desmoglein 3</strong>, is seen in Pemphigus vulgaris.</span></li><li><span style=\"font-size:12pt;\"><strong>Desmoglein 1&nbsp;</strong>antibodies are also occasionally associated.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture29.jpg\" alt=\"\" width=\"600\" height=\"559\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Usually, the antibodies are <strong>IgG antibodies</strong>. The skin and mucosa's <strong>basal and suprabasal</strong> layers contain the majority of <strong>Desmoglein 3</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Hemidesmosomes&nbsp;</strong>help in connecting <strong>basal layer </strong>to underlying <strong>dermo-epidermal junction</strong>, in <strong>pemphigus vulgaris</strong> there are <strong>no antibodies</strong> against <strong>Hemidesmosomes</strong>, so the basal layer remains attached to the underlying dermo-epidermal junction giving the classical <strong>Row of tombstones appearance</strong>.</span></li><li><span style=\"font-size:12pt;\">The patients, therefore, present with <strong>flaccid bullae over the skin</strong> and due to Desmoglein 3 involvement, mucosal involvement can also be seen.</span></li><li><span style=\"font-size:12pt;\"><strong>Oral mucosa is commonly affected</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture30.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Other areas where ulceration can be seen are <strong>conjunctiva</strong>, <strong>nasopharynx, larynx</strong>, etc.</span></li><li><span style=\"font-size:12pt;\">Cutaneous lesions are more common over the <strong>scalp, face, neck, upper chest, and back as seen in the image below.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture31.jpg\" alt=\"\" width=\"400\" height=\"302\"></strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Biopsy:&nbsp;</strong>The basal layer remains adherent to the basement membrane and gives the resemblance to a <strong>row of tombstones.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13497.jpg\" alt=\"\" width=\"600\" height=\"214\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">IMAGE of row of tombstones appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Psoriasis vulgaris:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is an <strong>autoimmune</strong> disease characterized by <strong>hyperproliferation of keratinocytes</strong> leading to thickened, <strong>scaly plaques</strong>.</span></li><li><span style=\"font-size:12pt;\">Histologically, it shows <strong>parakeratosis</strong> (<strong>retention of nuclei </strong>in the stratum c<strong>orneum</strong>), elongation of <strong>rete ridges</strong>, and a <strong>neutrophilic </strong>infiltrate (<strong>Munro's </strong>microabscesses) as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture32.jpg\" alt=\"\" width=\"400\" height=\"178\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The tombstone appearance is not a feature of psoriasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Leishmaniasis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It's a <strong>parasitic</strong> infection caused by the <strong>Leishmania</strong> species.</span></li><li><span style=\"font-size:12pt;\">Histologically, it is characterized by <strong>macrophages</strong> containing the <strong>parasite</strong> <strong>(Leishman-Donovan bodies</strong>) in the <strong>dermis </strong>as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture33.jpg\" alt=\"\" width=\"400\" height=\"398\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The tombstone appearance is not seen in leishmaniasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mycosis fungoides:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is a type of <strong>cutaneous T-cell lymphoma</strong>.</span></li><li><span style=\"font-size:12pt;\">Histologically, there is an <strong>atypical lymphocytic </strong>infiltrate in the epidermis <strong>(epidermotropism</strong>), and the formation of <strong>Pautrier's microabscesses </strong>(collections of l<strong>ymphocytes</strong> in the epidermis) as shown in the image below.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture34.jpg\" alt=\"\" width=\"400\" height=\"227\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It does <strong>not</strong> exhibit a <strong>tombstone appearance</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-180630.jpg\" alt=\"\" width=\"1000\" height=\"596\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The histopathology image suggests <strong>Pemphigus vulgaris</strong>, which is characterized by <strong>intraepidermal blistering</strong> due to <strong>acantholysis</strong>, or <strong>separation of keratinocytes</strong>, as a result of <strong>autoantibody</strong> attack on <strong>desmosomal proteins.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology - 9th Edition Chapter 50 Page no 50.1</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Robbins &amp; cotran Pathologic Basis of disease 10e- page no 1160</strong></span></p>",
    "correct_choice_id": 39697,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4225,
    "choices": [
      {
        "id": 16877,
        "text": "<p><span style=\"font-size:12.0pt;\">Posterior canal BPPV</span></p>"
      },
      {
        "id": 16878,
        "text": "<p><span style=\"font-size:12.0pt;\">Superior canal BPPV</span></p>"
      },
      {
        "id": 16879,
        "text": "<p><span style=\"font-size:12.0pt;\">Right hypoactive labyrinth</span></p>"
      },
      {
        "id": 16880,
        "text": "<p><span style=\"font-size:12.0pt;\">Left hypoactive labyrinth</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with vertigo associated with horizontal nystagmus. The slow component is towards the left. What is the most likely diagnosis?(</span>INICET May 2022)</p>",
    "unique_key": "Q7319022",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822844,
    "difficulty_level": "intermediate",
    "subjects_id": [
      9
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Left hypoactive labyrinth</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A left hypoactive labyrinth is the most likely diagnosis based on the clinical features.</span></li><li><span style=\"font-size:12.0pt;\">Vestibular nystagmus has a slow and fast component.</span></li><li><span style=\"font-size:12.0pt;\">The fast component denotes the direction of the nystagmus.</span></li><li><span style=\"font-size:12.0pt;\">Paretic lesions such as purulent labyrinthitis, and trauma to the labyrinth cause nystagmus to the healthy side.</span></li><li><span style=\"font-size:12.0pt;\">Serous labyrinthitis (irritative lesion) leads to nystagmus on the same side of the lesion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Posterior canal BPPV</strong>: Characterized by positional vertigo and typically vertical nystagmus, related to the posterior semicircular canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Superior canal BPPV</strong>: Also known as anterior canal BPPV, would cause primarily vertically oriented nystagmus, not horizontal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Right hypoactive labyrinth</strong>: Would produce nystagmus with the slow component towards the right and the fast component towards the left, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The direction of the slow and fast components of nystagmus is crucial in diagnosing the affected side in vestibular disorders. A left hypoactive labyrinth leads to nystagmus with a fast component to the right, matching the clinical presentation in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 43</strong></span></p>",
    "correct_choice_id": 16880,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16057,
    "choices": [
      {
        "id": 64188,
        "text": "<p><span style=\"font-size:12.0pt;\">III</span></p>"
      },
      {
        "id": 64189,
        "text": "<p><span style=\"font-size:12.0pt;\">VII</span></p>"
      },
      {
        "id": 64190,
        "text": "<p><span style=\"font-size:12.0pt;\">IV</span></p>"
      },
      {
        "id": 64191,
        "text": "<p><span style=\"font-size:12.0pt;\">VI</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the cranial nerve passing through the given structure: (</span>INICET Nov 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/ai-16.jpg\" alt=\"\" width=\"286\" height=\"333\"></span></p>",
    "unique_key": "Q9761305",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822820,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. IV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given image, the dorsal aspect of the brainstem is marked and the cranial nerve that is passing there is the trochlear nerve (CN IV).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Trochlear nerve</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong> : The trochlear nerve is the only cranial nerve that emerges from the dorsal (posterior) aspect of the brain. Specifically, it originates from the dorsal surface of the midbrain, below the inferior colliculus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit </strong>proceed to the superior orbital fissure to enter the orbit.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It is a motor nerve that innervates a single extraocular muscle, the superior oblique muscle. The primary action of the superior oblique muscle is to intort (rotate inward), depress, and abduct the eyeball.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Oculomotor Nerve (III):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The oculomotor nerve originates in the anterior aspect of the midbrain. Specifically, its fibers arise from the oculomotor nucleus, which is located in the superior colliculus of the midbrain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: After emerging from the midbrain, it exits the brainstem at the level of the interpeduncular fossa (the space between the cerebral peduncles).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It innervates most of the muscles controlling eye movements. It also contains parasympathetic fibers that are involved in pupil constriction and the lens's accommodation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Facial Nerve (VII):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The facial nerve arises from the pons. Specifically, its fibers come from the facial nerve nucleus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: It emerges from the brainstem at the cerebellopontine angle, between the pons and the medulla. It exits lateral to the abducens nerve and medial to the vestibulocochlear nerve (VIII).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: The facial nerve controls the muscles of facial expression. It also has taste fibers from the anterior two-thirds of the tongue and carries parasympathetic fibers to salivary and lacrimal glands.</span><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Abducens Nerve (VI):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Origin</strong>: The abducens nerve originates in the pons. Its fibers arise from the abducens nucleus, which is located in the dorsal pons near the floor of the fourth ventricle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Exit Point</strong>: It emerges from the ventral surface of the brainstem at the junction between the pons and the medulla, in the groove between the pons and the pyramid of the medulla.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Function</strong>: It innervates the lateral rectus muscle, which abducts the eye.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The trochlear nerve is the fourth cranial nerve that originates in the midbrain at the level of the inferior colliculus from the trochlear nuclei. It is the only cranial nerve that emerges from the brainstem's dorsal surface and has the longest intracranial course.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The main actions of superior oblique are:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Depression in adducted position- Patients with trochlear nerve palsy have difficulty in looking downwards when eyes are in the adducted position.</span></li><li><span style=\"font-size:12.0pt;\">Abduction</span></li><li><span style=\"font-size:12.0pt;\">Intorsion of the eyeball.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-194331.JPG\" alt=\"\" width=\"1000\" height=\"471\"></span></p>",
    "correct_choice_id": 64190,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4529,
    "choices": [
      {
        "id": 18092,
        "text": "<p><span style=\"font-size:12.0pt;\">Ligamentum flavum</span></p>"
      },
      {
        "id": 18093,
        "text": "<p><span style=\"font-size:12.0pt;\">Dura mater</span></p>"
      },
      {
        "id": 18094,
        "text": "<p><span style=\"font-size:12.0pt;\">Arachnoid mater</span></p>"
      },
      {
        "id": 18095,
        "text": "<p><span style=\"font-size:12.0pt;\">Pia mater</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presented with headache, vomiting, and fever. Meningitis was suspected. While performing a lumbar puncture, which is the last structure you will pierce just before entering the lumbar cistern? (NEET PG 2021)</span></p>",
    "unique_key": "Q1138371",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822647,
    "difficulty_level": "beginner",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Arachnoid mater</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arachnoid mater is the last structure you will pierce while performing a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Layers pierced while performing lumbar puncture/spinal anesthesia (subarachnoid space) from outside to inside are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Skin</span></li><li><span style=\"font-size:12.0pt;\">Subcutaneous tissue</span></li><li><span style=\"font-size:12.0pt;\">Supraspinous ligament</span></li><li><span style=\"font-size:12.0pt;\">Interspinous ligament</span></li><li><span style=\"font-size:12.0pt;\">Ligamentum flavum</span></li><li><span style=\"font-size:12.0pt;\">Dura mater</span></li><li><span style=\"font-size:12.0pt;\">Arachnoid mater</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Upon piercing the arachnoid mater, you enter the subarachnoid space (lumbar cistern), where cerebrospinal fluid (CSF) is collected during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ligamentum flavum: </strong>The ligamentum flavum is a strong ligament that connects the laminae of the vertebrae. It is pierced before the dura mater during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dura mater: </strong>The dura mater is a tough outer meningeal layer that is pierced before the arachnoid mater during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pia mater: </strong>The pia mater is the innermost meningeal layer that directly covers the spinal cord. It is not pierced during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arachnoid mater is the last structure pierced before entering the lumbar cistern during a lumbar puncture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/untitled-961.jpg\" alt=\"\" width=\"300\" height=\"270\"></span></p>",
    "correct_choice_id": 18094,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7175,
    "choices": [
      {
        "id": 28668,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypotension</span></span></span></p>"
      },
      {
        "id": 28669,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyponatremia</span></span></span></p>"
      },
      {
        "id": 28670,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rash</span></span></span></p>"
      },
      {
        "id": 28671,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated levels of gamma glutamyl transpeptidas</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following side effects are more commonly seen with carbamazepine than oxcarbazepine, except: (</span></span>INICET Nov 2022)</p>",
    "unique_key": "Q2800374",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822655,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Hyponatremia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyponatremia is more commonly observed in individuals taking oxcarbazepine compared to those taking carbamazepine. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both of these antiepileptic drugs can contribute to hyponatremia by enhancing the effects of ADH (antidiuretic hormone), leading to increased retention of water, which in turn reduces the osmolarity and causes hyponatremia. However, the incidence of hyponatremia appears to be higher with oxcarbazepine when compared to carbamazepine.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Hypotension</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hypotension is more commonly seen with carbamazepine. It can affect cardiovascular function and lead to decreased blood pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Rash</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rash is a common side effect of both drugs, but it is more frequently seen with carbamazepine. Skin reactions can range from mild to severe, including Stevens-Johnson syndrome and toxic epidermal necrolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Elevated levels of gamma glutamyl transpeptidases (GGT)</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Elevated GGT levels are more commonly associated with carbamazepine use. GGT is an enzyme found in the liver, and its elevated levels can indicate liver enzyme induction or liver injury, which is more common with carbamazepine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyponatremia is more commonly associated with oxcarbazepine than carbamazepine. While both drugs can cause similar side effects due to their similar mechanisms of action, certain adverse effects, such as hypotension, rash, and elevated GGT levels, are more frequently seen with carbamazepine.</span></span></span></p>",
    "correct_choice_id": 28669,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4531,
    "choices": [
      {
        "id": 18100,
        "text": "<p><span style=\"font-size:12.0pt;\">CPR with 20% intralipid</span></p>"
      },
      {
        "id": 18101,
        "text": "<p><span style=\"font-size:12.0pt;\">CPR with sodium bicarbonate</span></p>"
      },
      {
        "id": 18102,
        "text": "<p><span style=\"font-size:12.0pt;\">CPR with dobutamine</span></p>"
      },
      {
        "id": 18103,
        "text": "<p><span style=\"font-size:12.0pt;\">CPR with calcium</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A young male patient was given regional block with 0.25% bupivacaine for a minor surgical procedure.&nbsp;Shortly after the injection, the patient suddenly became unresponsive and the pulse was not recordable. Which of the following would be the best course of management for this patient? (NEET PG 2021)</span></p>",
    "unique_key": "Q8068662",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822648,
    "difficulty_level": "beginner",
    "subjects_id": [
      19
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) CPR with 20% intralipid</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The scenario described involves a young male patient who received a regional block with 0.25% bupivacaine for a minor surgical procedure and subsequently became unresponsive with an unrecordable pulse.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;These are concerning signs of Local Anesthetic Systemic Toxicity (LAST), which can occur when local anesthetic drugs like bupivacaine enter the systemic circulation.</span></li><li><span style=\"font-size:12.0pt;\">The best course of management for this patient is as follows:</span></li><li><span style=\"font-size:12.0pt;\">This is the correct choice. Intralipid is a lipid emulsion used as the antidote for LAST.</span></li><li><span style=\"font-size:12.0pt;\">It works by sequestering the local anesthetic drug in the lipid phase and reducing its toxic effects on the cardiovascular and central nervous systems.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;CPR (Cardiopulmonary Resuscitation) should be initiated, and 20% intralipid should be administered intravenously to treat LAST.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CPR with sodium bicarbonate</strong>: Sodium bicarbonate is not the first-line treatment for LAST. While it can be used to treat certain cardiac arrhythmias caused by local anesthetic toxicity, it does not directly counteract the toxic effects on the central nervous system and is not as effective as intralipid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CPR with dobutamine</strong>: Dobutamine is a medication used to increase cardiac output and blood pressure in some situations, but it is not the primary treatment for LAST.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CPR with calcium:</strong> Calcium does not reverse the toxic effects of local anesthetic systemic toxicity. Therefore, it is not the appropriate treatment for this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">When a patient experiences LAST with signs of cardiovascular collapse and central nervous system toxicity, the recommended treatment is CPR (if necessary) along with the administration of 20% intralipid intravenously, as it helps to reverse the toxic effects of the local anesthetic and improve the patient's condition.</span></li><li><span style=\"font-size:12.0pt;\">Drug of choice for treatment of LAST \u2013 20% Intralipid IV</span></li></ul>",
    "correct_choice_id": 18100,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7135,
    "choices": [
      {
        "id": 28508,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varenicline</span></span></span></p>"
      },
      {
        "id": 28509,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Buspirone </span></span></span></p>"
      },
      {
        "id": 28510,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nicotine gum</span></span></span></p>"
      },
      {
        "id": 28511,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rimonabant</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most effective drug in smoking cessation?(</span></span>INICET Nov 2021)</p>",
    "unique_key": "Q6552982",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822819,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Varenicline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varenicline is the most effective drug in smoking cessation. Varenicline is a partial agonist at the &alpha;4&beta;2 nicotinic receptors. It is one of the 1<sup>st</sup> line oral drugs that is used for smoking cessation. The other drugs are Bupropion, even Nicotine replacement in the form of gums, lozenge, patch, spray can also be used.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Buspirone:</span></strong><span style=\"font-size:12.0pt\"> Primarily used for the treatment of anxiety disorders, buspirone is not used for smoking cessation. Bupropion is used for smoking cessation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nicotine gum:</span></strong><span style=\"font-size:12.0pt\"> As a form of nicotine replacement therapy (NRT), nicotine gum helps to reduce withdrawal symptoms and cravings by supplying a small amount of nicotine. While effective for many people, it may be less effective than prescription medications like varenicline, especially for heavy smokers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Rimonabant:</span></strong><span style=\"font-size:12.0pt\"> This drug was initially developed as an anti-obesity medication and was found to also have some effect on smoking cessation. However, it was withdrawn from the market due to psychiatric side effects, including depression and suicidal thoughts.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varenicline is the most effective medication for smoking cessation. It works as a partial agonist at nicotinic receptors, helping to alleviate withdrawal symptoms and reduce the rewarding effects of nicotine. This makes it a highly effective option for individuals seeking to quit smoking.</span></span></span></p>",
    "correct_choice_id": 28508,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3464,
    "choices": [
      {
        "id": 13835,
        "text": "<p>1</p>"
      },
      {
        "id": 13836,
        "text": "<p>2</p>"
      },
      {
        "id": 13837,
        "text": "<p>3</p>"
      },
      {
        "id": 13838,
        "text": "<p>4</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the enzyme conjugate in the given ELISA technique?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-27.jpg\" alt=\"\" width=\"400\" height=\"508\"></span></p>",
    "unique_key": "Q3525442",
    "question_audio": null,
    "question_video": null,
    "map_id": 32822847,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The enzyme conjugate in the given ELISA technique is '2'.</span></p><p>&nbsp;</p><p><img class=\"image_resized\" style=\"aspect-ratio:750/826;width:96.63%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1%20(1)_A6DXgWV.png\" width=\"750\" height=\"826\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The sandwich ELISA&nbsp;</strong>is a type of Enzyme-linked immunosorbent Assay that uses two antibodies: a capture antibody and a detection antibody. It is called a sandwich because your antigen is bound between antibodies. <strong>The purpose of any ELISA is to detect the presence of a target antigen</strong> in a sample. <u>In a sandwich ELISA the target antigen is bound between a capture antibody and a detection antibody.</u> The capture antibody is immobilized on a surface, while the detection antibody (conjugated to an enzyme or fluorophore label) is applied as a last step before quantitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1</strong>: Represents the substrate that produces a detectable signal when reacted with the enzyme.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>3</strong>: Represents the primary detection antibody that binds to the antigen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 4</strong>: Represents the capture antibody that is immobilized on the surface and captures the antigen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the sandwich ELISA technique, the enzyme conjugate is part of the detection antibody, which binds to the antigen and, upon addition of a substrate, produces a detectable signal. In this diagram, '2' is identified as the enzyme conjugate.</span></p>",
    "correct_choice_id": 13836,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ImageBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq (Inicet, Mixed Bag-3)';
        const quizFilename = 'late-night-pyq-inicet-mixed-bag-3-9427372a.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>